Survival Rate

• 

  Subject Areas on Research

  • "All hands on deck": An imperative for tackling hypertension in South Asia. 
  • "Hybrid" repair of aneurysms of the transverse aortic arch: midterm results. 
  • "Real world" thoracic endografting: results with the Gore TAG device 2 years after U.S. FDA approval. 
  • "Rescue" platelet GP IIb/IIIa inhibitor therapy in percutaneous coronary intervention: bailing out of a sunken ship. 
  • (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study. 
  • 100 consecutive liver transplants in infants and children: an 8-year experience. 
  • 30-Day risk-standardized mortality and readmission rates after ischemic stroke in critical access hospitals. 
  • 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers. 
  • 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. 
  • 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. 
  • 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. 
  • 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. 
  • 5α-Reductase inhibition coupled with short off cycles increases survival in the LNCaP xenograft prostate tumor model on intermittent androgen deprivation therapy. 
  • A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation. 
  • A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. 
  • A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603). 
  • A Comprehensive Review of Outcome Predictors in Low MELD Patients. 
  • A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis. 
  • A Critical Appraisal of Short-Term End Points in Acute Heart Failure Clinical Trials. 
  • A Minimally Invasive Approach to Lobectomy After Induction Therapy Does Not Compromise Survival. 
  • A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer. 
  • A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer. 
  • A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer. 
  • A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality. 
  • A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. 
  • A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. 
  • A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncology Group. 
  • A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse. 
  • A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. 
  • A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer. 
  • A Propensity-matched Survival Analysis: Do Simultaneous Liver-lung Transplant Recipients Need a Liver? 
  • A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2). 
  • A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer. 
  • A Risk-prediction Model Based on Lymph-node Metastasis for Incorporation Into a Treatment Algorithm for Signet Ring Cell-type Intramucosal Gastric Cancer. 
  • A comparison of 399 open and 568 laparoscopic gastric bypasses performed during a 4-year period. 
  • A comparison of laparoscopically assisted and open colectomy for colon cancer. 
  • A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis. 
  • A comparison of operation, endoscopic retrograde cholangiopancreatography, and percutaneous transhepatic cholangiography in biliary complications after hepatic transplantation. 
  • A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer. The Piedmont Oncology Association experience. 
  • A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma. 
  • A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study. 
  • A copula approach for detecting prognostic genes associated with survival outcome in microarray studies. 
  • A cost analysis of hematopoietic colony-stimulating factors. 
  • A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. 
  • A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer. 
  • A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer. 
  • A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent. 
  • A literature-based treatment algorithm for low-grade neuroendocrine liver metastases. 
  • A long-term experience with expansion of Milan criteria for liver transplant recipients. 
  • A longitudinal study of the effects of tobacco smoking and other modifiable risk factors on ill health in middle-aged and old Americans: results from the Health and Retirement Study and Asset and Health Dynamics among the Oldest Old survey. 
  • A model of sequential heart and composite tissue allotransplant in rats. 
  • A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion. 
  • A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy. 
  • A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans Affairs. 
  • A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. 
  • A nomogram for individualized estimation of survival among patients with brain metastasis. 
  • A novel survival model of cardioplegic arrest and cardiopulmonary bypass in rats: a methodology paper. 
  • A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML. 
  • A phase 2 randomized trial of paclitaxel and carboplatin with or without panitumumab for first-line treatment of advanced non-small-cell lung cancer. 
  • A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia. 
  • A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer. 
  • A phase I trial of human gamma interferon transduced autologous tumor cells in patients with disseminated malignant melanoma. 
  • A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma. 
  • A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma. 
  • A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226. 
  • A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer. 
  • A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. 
  • A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study. 
  • A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study. 
  • A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. 
  • A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer. 
  • A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104. 
  • A phase II study of cisplatin, 5-fluorouracil, leucovorin, and etoposide in advanced non-small-cell lung cancer. 
  • A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602). 
  • A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813. 
  • A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study. 
  • A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study. 
  • A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer. 
  • A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer. 
  • A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307. 
  • A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. 
  • A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer. 
  • A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancer. 
  • A phase II trial of interferon-alpha and toremifene in advanced renal cell cancer patients. 
  • A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance). 
  • A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801. 
  • A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium. 
  • A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma. 
  • A pilot study of etoposide, vinblastine, and doxorubicin plus involved field irradiation in advanced, previously untreated Hodgkin's disease. 
  • A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. 
  • A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. 
  • A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma. 
  • A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease. 
  • A prognostic model for patients with end-stage liver disease. 
  • A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. 
  • A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients. 
  • A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. 
  • A purified diet for medaka (Oryzias latipes): refining a fish model for toxicological research. 
  • A randomised trial of lung sealant versus medical therapy for advanced emphysema. 
  • A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. 
  • A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy. 
  • A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer. 
  • A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181. 
  • A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. 
  • A randomized trial of glutamine and antioxidants in critically ill patients. 
  • A reduced-toxicity regimen is associated with durable engraftment and clinical cure of nonmalignant genetic diseases among children undergoing blood and marrow transplantation with an HLA-matched related donor. 
  • A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia. 
  • A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. 
  • A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. 
  • A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage. 
  • A safe approach to the treatment of iliac artery aneurysms. Aortobifemoral bypass grafting with exclusion of the aneurysm. 
  • A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer. 
  • A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment. 
  • ABO blood group influences transfusion and survival after cardiac surgery. 
  • ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas. 
  • AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. 
  • AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma. 
  • ANZCCSG BabyBrain99; intensified systemic chemotherapy, second look surgery and involved field radiation in young children with central nervous system malignancy. 
  • APOE genotype affects outcome in a murine model of sepsis: implications for a new treatment strategy. 
  • Abdominoperineal Resection for Rectal Cancer in the Twenty-First Century: Indications, Techniques, and Outcomes. 
  • Aberrant expression of tumor suppressor proteins in the Ewing family of tumors. 
  • Aberrant promoter methylation of multiple genes in non-small cell lung cancers. 
  • Abundance and survival rates of the Hawai'i Island associated spinner dolphin (Stenella longirostris) stock. 
  • Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients). 
  • Acral melanoma: a review of 185 patients with identification of prognostic variables. 
  • Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis. 
  • Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma. 
  • Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? 
  • Acute cellular and antibody-mediated allograft rejection. 
  • Acute coronary syndromes: introducing new therapies into established guidelines. 
  • Acute kidney injury after ex vivo lung perfusion (EVLP). 
  • Acute kidney injury in HIV-infected patients. 
  • Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. 
  • Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. 
  • Acute pancreatitis and fulminant hepatic failure. 
  • Acute respiratory distress syndrome in the trauma intensive care unit: Morbid but not mortal. 
  • Acyclovir in human immunodeficiency virus patients. 
  • Adaptive mechanisms that preserve cardiac function in mice without myoglobin. 
  • Added benefit of mineralocorticoid receptor blockade in the primary prevention of sudden cardiac death. 
  • Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer. 
  • Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials. 
  • Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data. 
  • Adenoid cystic carcinoma of the paranasal sinuses. 
  • Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. 
  • Adherence to Guidelines for Screening and Medication Use: Mortality and Onset of Major Macrovascular Complications in Elderly Persons With Diabetes Mellitus. 
  • Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. 
  • Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). 
  • Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response. 
  • Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas. 
  • Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up. 
  • Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer. 
  • Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis. 
  • Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection. 
  • Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma. 
  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. 
  • Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry. 
  • Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. 
  • Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial. 
  • Adjuvant therapy for colorectal cancer. 
  • Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy? 
  • Admission cell free DNA levels predict 28-day mortality in patients with severe sepsis in intensive care. 
  • Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). 
  • Admission oxygenation and ventilation parameters associated with discharge survival in severe pediatric traumatic brain injury. 
  • Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims. 
  • Adult surgical experience with Loeys-Dietz syndrome. 
  • Advanced age is an independent predictor for increased morbidity and mortality after emergent surgery for diverticulitis. 
  • Advances in pancreas transplantation: the University of Wisconsin experience. 
  • Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202. 
  • Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. 
  • Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. 
  • After Action Reviews. 
  • Age as a prognostic factor in the malignant melanoma population. 
  • Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction. 
  • Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry. 
  • Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients. 
  • Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. 
  • Allergies, obesity, other risk factors and survival from pancreatic cancer. 
  • Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia. 
  • Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery. 
  • Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results. 
  • Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. 
  • Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. 
  • Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. 
  • Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. 
  • Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors. 
  • Alpha-1 adrenoceptor-angiotensin II type 1 receptor cross-talk and its relevance in clinical medicine. 
  • Alternative conduits for coronary revascularization: a novel approach for harvest of the lesser saphenous vein. 
  • Alternative pay-for-performance scoring methods: implications for quality improvement and patient outcomes. 
  • American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). 
  • American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. 
  • Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial. 
  • Amyotrophic lateral sclerosis: current practice and future treatments. 
  • An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study Group. 
  • An archival prospective study of mental health and longevity. 
  • An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience. 
  • An integrated genomic analysis of human glioblastoma multiforme. 
  • Anaemia and coronary artery disease severity in patients with heart failure. 
  • Anal cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. 
  • Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. 
  • Analysis of 945 cases of pulmonary metastatic melanoma. 
  • Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. 
  • Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. 
  • Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. 
  • Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma. 
  • Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the Surveillance, Epidemiology, and End Results database. 
  • Analysis of prognosis and disease progression after local recurrence of melanoma. 
  • Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. 
  • Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization. 
  • Anatomic tumor location influences the success of contemporary limb-sparing surgery and radiation among adults with soft tissue sarcomas of the extremities. 
  • Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. 
  • Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel. 
  • Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. 
  • Angiomirs expression profiling in diffuse large B-Cell lymphoma. 
  • Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome. 
  • Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. 
  • Annual financial impact of well-differentiated thyroid cancer care in the United States. 
  • Anorectal melanoma: clinical characteristics and the role of abdominoperineal resection. 
  • Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge. 
  • Anti-inflammatory adjuvant in resuscitation fluids improves survival in hemorrhage. 
  • Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response. 
  • Antibody desensitization therapy in highly sensitized lung transplant candidates. 
  • Antibody to E- and L-selectin does not prevent lung injury or mortality in septic baboons. 
  • Antibody to intercellular adhesion molecule 1 (CD54) decreases survival and not lung injury in baboons with sepsis. 
  • Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). 
  • Anticoagulation in heart failure: current status and future direction. 
  • Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System. 
  • Antidiabetic therapies affect risk of pancreatic cancer. 
  • Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population. 
  • Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE. 
  • Aortic dissection resulting from tear of transverse arch: is concomitant arch repair warranted? 
  • ApoE genotype and survival from intracerebral haemorrhage. 
  • Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. 
  • Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. 
  • Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. 
  • Appendiceal carcinoma: patterns of failure following surgery and implications for adjuvant therapy. 
  • Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis. 
  • Aquaporin 4 blockade improves survival of murine heart allografts subjected to prolonged cold ischemia. 
  • Aquaporin 9 is the major pathway for glycerol uptake by mouse erythrocytes, with implications for malarial virulence. 
  • Arrhythmogenic right ventricular dysplasia: a United States experience. 
  • Artificial neural networks improve the accuracy of cancer survival prediction. 
  • Assessing surrogacy using restricted mean survival time ratio for overall survival in non-small cell lung cancer immunotherapy studies. 
  • Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer. 
  • Assessing the causal effect of organ transplantation on the distribution of residual lifetime. 
  • Assessing the clinical and economic burden of coronary artery disease: 1986-1998. 
  • Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. 
  • Assessment of different threshold preoperative glomerular filtration rates as markers of outcomes in lung transplantation. 
  • Assessment of objective responses using volumetric evaluation in advanced thymic malignancies and metastatic non-small cell lung cancer. 
  • Assessment of selection bias in clinic-based populations of childhood cancer survivors: a report from the childhood cancer survivor study. 
  • Association Between Driving Distance From Nearest Fire Station and  Survival of Out-of-Hospital Cardiac Arrest. 
  • Association Between Inferior Vena Cava Filter Insertion in Trauma Patients and In-Hospital and Overall Mortality. 
  • Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel. 
  • Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial). 
  • Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer. 
  • Association between bilirubin and mode of death in severe systolic heart failure. 
  • Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial. 
  • Association between body mass index and mortality in patients with glioblastoma mutliforme. 
  • Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy. 
  • Association between hospital post-resuscitative performance and clinical outcomes after out-of-hospital cardiac arrest. 
  • Association between reproductive factors and breast cancer survival in younger women. 
  • Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study. 
  • Association of Bystander and First-Responder Efforts and Outcomes According to Sex: Results From the North Carolina HeartRescue Statewide Quality Improvement Initiative. 
  • Association of CASP7 polymorphisms and survival of patients with non-small cell lung cancer with platinum-based chemotherapy treatment. 
  • Association of COVID-19 Infection With Survival After In-Hospital Cardiac Arrest Among US Adults. 
  • Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population. 
  • Association of Daytime and Nighttime Blood Pressure With Cardiovascular Disease Events Among African American Individuals. 
  • Association of Delivery System Integration and Outcomes for Major Cancer Surgery. 
  • Association of Early Stress Testing with Outcomes for Emergency Department Evaluation of Suspected Acute Coronary Syndrome. 
  • Association of Exercise With Mortality in Adult Survivors of Childhood Cancer. 
  • Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry. 
  • Association of Implantable Device Measured Physical Activity With Hospitalization for Heart Failure. 
  • Association of Lymph Node Ratio With Overall Survival in Patients With Metastatic Papillary Thyroid Cancer. 
  • Association of Lymphopenia With Risk of Mortality Among Adults in the US General Population. 
  • Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype. 
  • Association of Public Health Initiatives With Outcomes for Out-of-Hospital Cardiac Arrest at Home and in Public Locations. 
  • Association of VA Payment Reform for Dialysis with Spending, Access to Care, and Outcomes for Veterans with ESKD. 
  • Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality. 
  • Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction. 
  • Association of anemia and long-term survival in patients with pulmonary hypertension. 
  • Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. 
  • Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF). 
  • Association of body mass index and long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction: results from the CRUSADE Registry. 
  • Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community. 
  • Association of depression and survival in patients with chronic heart failure over 12 Years. 
  • Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry. 
  • Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer. 
  • Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program. 
  • Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. 
  • Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis. 
  • Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. 
  • Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients. 
  • Association of postoperative complications and outcomes following coronary artery bypass grafting. 
  • Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer. 
  • Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease. 
  • Association of standard clinical and laboratory variables with red blood cell distribution width. 
  • Association of the frontal QRS-T angle with adverse cardiac remodeling, impaired left and right ventricular function, and worse outcomes in heart failure with preserved ejection fraction. 
  • Association of weight change with subsequent outcomes in patients hospitalized with acute decompensated heart failure. 
  • Associations Between Unplanned Cardiac Reinterventions and Outcomes After Pediatric Cardiac Operations. 
  • Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901. 
  • Associations between anthropometric indices and outcomes of congenital heart operations in infants and young children: An analysis of data from the Society of Thoracic Surgeons Database. 
  • Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma. 
  • Associations between seattle heart failure model scores and medical resource use and costs: findings from HF-ACTION. 
  • Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure. 
  • Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. 
  • Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. 
  • Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries. 
  • Atrial Fibrillation and Heart Failure: In This Challenge Lies Opportunity. 
  • Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction. 
  • Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices. 
  • Atrioventricular and ventricular-to-ventricular programming in patients with cardiac resynchronization therapy: results from ALTITUDE. 
  • Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. 
  • Autologous bone marrow transplantation for acute lymphoblastic leukemia. 
  • Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. 
  • Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. 
  • Autologous transplantation for relapsed non-Hodgkin's lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience. 
  • Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival. 
  • Axial Muscle Size as a Strong Predictor of Death in Subjects With and Without Heart Failure. 
  • Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and Survival. 
  • B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality. 
  • B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review. 
  • B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence. 
  • BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. 
  • BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. 
  • BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial. 
  • BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis. 
  • Balloon aortic valvuloplasty. 
  • Barriers to cardiac transplantation in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study. 
  • Baseline 6-min walk distance predicts survival in lung transplant candidates. 
  • Baseline body mass index does not significantly affect outcomes after pulmonary thromboendarterectomy. 
  • Bayesian analysis of proportional hazards models built from monotone functions. 
  • Bayesian inference on age-specific survival for censored and truncated data. 
  • Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons. 
  • Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. 
  • Beta1-adrenergic receptors maintain fetal heart rate and survival. 
  • Between-hospital variation in treatment and outcomes in extremely preterm infants. 
  • Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. 
  • Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance). 
  • Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study. 
  • Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracil-based regimens irrespective of baseline risk. 
  • Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. 
  • Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series. 
  • Beyond 5-fluorouracil: the emerging role of newer chemotherapeutics and targeted agents with radiation therapy. 
  • Beyond Depth of Invasion: Adverse Pathologic Tumor Features in Early Oral Tongue Squamous Cell Carcinoma. 
  • Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors. 
  • Biochemical modulation of 5-fluorouacil through dihydropyrimidine dehydrogenase inhibition: a Southwest Oncology Group phase II trial of eniluracil and 5-fluorouracil in advanced resistant colorectal cancer. 
  • Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. 
  • Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer. 
  • Biventricular Support With Intracorporeal, Continuous Flow, Centrifugal Ventricular Assist Devices. 
  • Black Race Is Associated with a Lower Risk of Bronchopulmonary Dysplasia. 
  • Bleeding complications and blood product utilization with left ventricular assist device implantation. 
  • Blinatumomab: A New Treatment for Adults With Relapsed Acute Lymphocytic Leukemia. 
  • Blood pressure reactivity to psychological stress is associated with clinical outcomes in patients with heart failure. 
  • Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: Epidemiology, risk factors, and mortality. 
  • Body composition and mortality after adult lung transplantation in the United States. 
  • Body mass index and nine-year mortality in disabled and nondisabled older U.S. individuals. 
  • Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. 
  • Body temperature and mortality in patients with acute respiratory distress syndrome. 
  • Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study. 
  • Bone marrow transplantation for thalassemia. The USA experience. 
  • Bone marrow transplantation from histocompatible sibling donors for patients with acute lymphoblastic leukemia. 
  • Bone marrow transplantation. Part I--Allogeneic. 
  • Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study. 
  • Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer. 
  • Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Carolina Resuscitation Research Group. 
  • Brain stem gliomas: patterns of care in Victoria from 1998-2000. 
  • Brainstem dysfunction as a predictor of death in the nonneurologically injured. 
  • Breast cancer after chest radiation therapy for childhood cancer. 
  • Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients. 
  • Breast cancer patients' treatment expectations after exposure to the decision aid program adjuvant online: the influence of numeracy. 
  • Breast conservation surgery using nipple-areolar resection for central breast cancers. 
  • Breast conservation: is the survival better for mastectomy? 
  • Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. 
  • Burden and Outcomes of Neonatal Surgery in Uganda: Results of a Five-Year Prospective Study. 
  • C-terminal deletion of the atrophin-1 protein results in growth retardation but not neurodegeneration in mice. 
  • CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer. 
  • CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET. 
  • CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers. 
  • CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. 
  • CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. 
  • CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables. 
  • CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation. 
  • COMPASS: A Pilot Trial of an Early Palliative Care Intervention for Patients With End-Stage Liver Disease. 
  • CT perfusion-derived mean transit time predicts early mortality and delayed vasospasm after experimental subarachnoid hemorrhage. 
  • CT screening for lung cancer: not ready for routine practice. 
  • Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial. 
  • Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment. 
  • Cancer in pregnancy: a review of the literature. Part I. 
  • Cancer prevention and screening practices of siblings of childhood cancer survivors: a report from the Childhood Cancer Survivor Study. 
  • Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. 
  • Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators. 
  • Carbonic anhydrase IX in early-stage non-small cell lung cancer. 
  • Carcinoid and chylous ascites: an unusual association. 
  • Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids. 
  • Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy. 
  • Carcinoma of the tonsillar region: a multivariate analysis of 243 patients treated with radical radiotherapy. 
  • Cardiac arrest and clinical characteristics, treatments and outcomes among patients hospitalized with ST-elevation myocardial infarction in contemporary practice: A report from the National Cardiovascular Data Registry. 
  • Cardiac biomarker measurement after elective percutaneous coronary interventions in older patients: insights from the National Cardiovascular Data Registry. 
  • Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. 
  • Cardiac transplantation at Duke University Medical Center. 
  • Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond. 
  • Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction". 
  • Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial. 
  • Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus. 
  • Cardiovascular events and hospital resource utilization pre- and post-transcatheter mitral valve repair in high-surgical risk patients. 
  • Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis. 
  • Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry. 
  • Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure. 
  • Case 24-1998: cholesterol atheroembolism. 
  • Cataract surgery and mortality. 
  • Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials. 
  • Causes of late mortality in pediatric liver transplant recipients. 
  • Cerebrospinal fluid shunt survival and etiology of failures: a seven-year institutional experience. 
  • Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. 
  • Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414). 
  • Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis. 
  • Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy. 
  • Changes in Risk Profile and Outcomes of Patients Undergoing Surgical Aortic Valve Replacement From the Pre- to Post-Transcatheter Aortic Valve Replacement Eras. 
  • Changes in health-related quality of life in off-pump versus on-pump cardiac surgery: Veterans Affairs Randomized On/Off Bypass trial. 
  • Changes in survival over time for primary brain and other CNS tumors in the United States, 2004-2017. 
  • Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. 
  • Changing patient characteristics and the effect on mortality in endocarditis. 
  • Changing spectrum of pediatric renal transplantation. 
  • Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis. 
  • Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of >500 Patients. 
  • Characteristics and outcomes in patients undergoing percutaneous coronary intervention following cardiac arrest (from the NCDR). 
  • Characteristics and outcomes of tumors arising from the distal nephron. 
  • Characteristics of Framingham offspring participants with long-lived parents. 
  • Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative. 
  • Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium. 
  • Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. 
  • Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis. 
  • Characterization of hemodynamically stable acute heart failure patients requiring a critical care unit admission: Derivation, validation, and refinement of a risk score. 
  • Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes. 
  • Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer. 
  • Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. 
  • Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial. 
  • Chemotherapy and radiation of anal canal cancer: the first approach. 
  • Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer. 
  • Chemotherapy in the elderly. 
  • Child survival, height for age and household characteristics in Brazil. 
  • Childhood malignant non-Hodgkin lymphomas of uncommon histology. 
  • Chloroquine improves survival and hematopoietic recovery after lethal low-dose-rate radiation. 
  • Chlorpyrifos exposure of developing zebrafish: effects on survival and long-term effects on response latency and spatial discrimination. 
  • Chronic Health Conditions and Neurocognitive Function in Aging Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. 
  • Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. 
  • Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. 
  • Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. 
  • Chronic thromboembolic pulmonary hypertension in pediatric patients. 
  • Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). 
  • Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data. 
  • Cisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration data. 
  • Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. 
  • Clinical Characteristics and Outcomes of Patients With Myocardial Infarction and Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Data From The Society of Thoracic Surgeons National Database. 
  • Clinical Outcomes of Mitral Valve Reoperations in the United States: An Analysis of The Society of Thoracic Surgeons National Database. 
  • Clinical and Echocardiographic Characteristics of Patients Hospitalized With Acute Versus Chronic Heart Failure With Preserved Ejection Fraction (From the ARIC Study). 
  • Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry. 
  • Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation. 
  • Clinical and echocardiographic predictors of mortality in acute pulmonary embolism. 
  • Clinical and economic lessons from studies of coronary thrombolysis. 
  • Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. 
  • Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment. 
  • Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: development of a predictive model. 
  • Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the International Collaboration on Endocarditis Merged Database. 
  • Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry. 
  • Clinical characteristics predict benefits from eptifibatide therapy during coronary stenting: insights from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy (ESPRIT) trial. 
  • Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION). 
  • Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade. 
  • Clinical correlation of previously undetected cancer-related incidental findings on CT planning scans for radiation therapy. 
  • Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. 
  • Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. 
  • Clinical evaluation of single versus multiple mammary artery bypass. 
  • Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. 
  • Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6. 
  • Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score. 
  • Clinical features and outcome of primary pancreatic lymphoma. 
  • Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial. 
  • Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS). 
  • Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. 
  • Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study. 
  • Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel. 
  • Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies. 
  • Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. 
  • Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. 
  • Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial. 
  • Clinical pathway to screen for cardiac amyloidosis in heart failure with preserved ejection fraction. 
  • Clinical presentation and outcome of retinoblastoma based on age at presentation: a review of 1450 children. 
  • Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial. 
  • Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial. 
  • Clinical prognostic model for older patients with advanced non-small cell lung cancer. 
  • Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence. 
  • Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence. 
  • Clinical trial end points for high-grade glioma: the evolving landscape. 
  • Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics? 
  • Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. 
  • Clinical, pathologic, and functional outcomes after nephron-sparing surgery in patients with a solitary kidney: a multicenter experience. 
  • Clinical, surgical, and molecular prognostic factors for survival after spinal sarcoma resection. 
  • Clinically localized prostatic carcinoma. 
  • Clinicopathologic factors relating to surgical margins for cutaneous melanoma. 
  • Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren's Classification. 
  • Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies. 
  • Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate. 
  • Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. 
  • Closed mitral valvotomy for mitral restenosis: experience in 113 consecutive cases. 
  • Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study. 
  • Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS). 
  • Colon sentinel lymph node mapping: practical surgical applications. 
  • Colorectal cancer: adjuvant chemotherapy for rectal cancer-an unresolved issue. 
  • Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes. 
  • Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS). 
  • Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. 
  • Combined free tissue transfer and infrainguinal bypass graft: an alternative to major amputation in selected patients. 
  • Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity. 
  • Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol. 
  • Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. 
  • Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. 
  • Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). 
  • Comparative effectiveness and safety of drug therapy for pulmonary arterial hypertension: a systematic review and meta-analysis. 
  • Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. 
  • Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial. 
  • Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. 
  • Comparative trials of chemotherapy and bone marrow transplantation in acute nonlymphocytic leukemia. 
  • Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon cancer. 
  • Comparing off-pump and on-pump clinical outcomes and costs for diabetic cardiac surgery patients. 
  • Comparing the prognostic performance of ASSIST to interleukin-6 and procalcitonin in patients with severe sepsis or septic shock. 
  • Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis. 
  • Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer. 
  • Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia. 
  • Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout. 
  • Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease). 
  • Comparison of Clinical characteristics and long-term outcomes of patients with ischemic cardiomyopathy with versus without angina pectoris (from the Duke Databank for Cardiovascular Disease). 
  • Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial. 
  • Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation. 
  • Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF). 
  • Comparison of Long-Term Mortality of Patients Aged ≤40 Versus >40 Years With Acute Myocardial Infarction. 
  • Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation. 
  • Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer. 
  • Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population. 
  • Comparison of balloon valvuloplasty with operative treatment for mitral stenosis. 
  • Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients. 
  • Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest. 
  • Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≥65 years with multivessel coronary artery disease. 
  • Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis. 
  • Comparison of intestinal lengthening procedures for patients with short bowel syndrome. 
  • Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies. 
  • Comparison of medical and surgical therapy for uncomplicated descending aortic dissection. 
  • Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease. 
  • Comparison of need for operative therapy in patients with mitral valve prolapse involving both leaflets versus posterior leaflet only. 
  • Comparison of omental and pectoralis flaps for poststernotomy mediastinitis. 
  • Comparison of outcome after coronary angioplasty and coronary surgery for multivessel coronary artery disease in persons with diabetes. 
  • Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. 
  • Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine. 
  • Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease. 
  • Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty. 
  • Comparison of survival of stage I-III colon cancer by travel distance and hospital volume. 
  • Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). 
  • Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS). 
  • Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group. 
  • Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. 
  • Competing Mortality in Patients With Neuroendocrine Tumors. 
  • Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes. 
  • Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010. 
  • Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. 
  • Completion Lymph Node Dissection or Radiation Therapy for Sentinel Node Metastasis in Merkel Cell Carcinoma. 
  • Complications arising after implantation of DDD pacemakers: the MOST experience. 
  • Complications in the surgical treatment of 19,360 cases of pediatric scoliosis: a review of the Scoliosis Research Society Morbidity and Mortality database. 
  • Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE. 
  • Comprehensive Surgical Treatment as the Mainstay of Management in Retroperitoneal Sarcomas: Retrospective Study from Two Non-sarcoma Specialist Centers. 
  • Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. 
  • Computational modelling of perivascular-niche dynamics for the optimization of treatment schedules for glioblastoma. 
  • Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer. 
  • Concomitant aortic and renal artery reconstruction in patients on an intensive antihypertensive medical regimen: long-term outcome. 
  • Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. 
  • Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53). 
  • Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer. 
  • Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer. 
  • Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary results. 
  • Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML. 
  • Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies. 
  • Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database. 
  • Connect MM Registry as a national reference for United States multiple myeloma patients. 
  • Conservative management of acute coronary syndrome: cheaper and better for you? 
  • Considerations of psychosocial illness phase in cancer survival. 
  • Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone. 
  • Construct validity of the definition of primary graft dysfunction after lung transplantation. 
  • Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker. 
  • Contemporary Demographic, Treatment, and Geographic Distribution Patterns for Disorders of Sex Development. 
  • Contemporary Outcomes of Surgical Repair of Total Anomalous Pulmonary Venous Connection in Patients With Heterotaxy Syndrome. 
  • Contemporary Surgical Management of Hypertrophic Cardiomyopathy in the United States. 
  • Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma. 
  • Contemporary surgical options for metastatic colorectal cancer. 
  • Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. 
  • Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer. 
  • Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin. 
  • Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. 
  • Contrasting methicillin-resistant Staphylococcus aureus colonization in Veterans Affairs and community nursing homes. 
  • Contributors to and impact of residual shunting after device closure of atrial septal defects. 
  • Controlled survival study of the effects of Tisseel or a combination of FloSeal and Tisseel on major vascular injury and major collecting-system injury during partial nephrectomy in a porcine model. 
  • Controversies regarding laparoscopic colectomy for malignant diseases. 
  • Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. 
  • Cord blood stem cells. 
  • Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial. 
  • Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction. 
  • Coronary artery bypass in patients with severely depressed ventricular function. 
  • Coronary revascularization in lung transplant recipients with concomitant coronary artery disease. 
  • Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. 
  • Correlated individual frailty: an advantageous approach to survival analysis of bivariate data. 
  • Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. 
  • Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. 
  • Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. 
  • Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. 
  • Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. 
  • Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. 
  • Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia. 
  • Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer. 
  • Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer. 
  • Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). 
  • Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? 
  • Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. 
  • Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer. 
  • Cost-effectiveness of the implantable cardioverter defibrillator. 
  • Cracking Chests without a Scratch: A Review of Emergency Department Thoracotomy Outcomes and Injuries to Providers at a Level II Trauma Center. 
  • Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS. 
  • Creation of a quantitative recipient risk index for mortality prediction after cardiac transplantation (IMPACT). 
  • Critical care aspects of lung transplantation. 
  • Critical review of radical cystectomy and indicators of prognosis. 
  • Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis. 
  • Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. 
  • Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. 
  • Current and novel pharmacologic approaches in advanced heart failure. 
  • Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry. 
  • Current management of esophageal variceal bleeding. 
  • Current status of hepatic resection. 
  • Current status of percutaneous PFO closure. 
  • Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution. 
  • Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen. 
  • Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses. 
  • Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival. 
  • Cytokine gene polymorphisms are not associated with bronchiolitis obliterans syndrome or survival after lung transplant. 
  • Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. 
  • Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. 
  • Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus-Trends and effect on overall survival. 
  • DC-CIK as a widely applicable cancer immunotherapy. 
  • DCIS with Microinvasion: Is It In Situ or Invasive Disease? 
  • DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML). 
  • DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial. 
  • DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer. 
  • DNA ploidy in nonseminomatous germ cell testicular tumor. 
  • De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation. 
  • Death in patients with permanent pacemakers for sick sinus syndrome. 
  • Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes. 
  • Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. 
  • Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation. 
  • Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. 
  • Defining surgical indications for type I gastric carcinoid tumor. 
  • Defining the learning curve for team-based laparoscopic pancreaticoduodenectomy. 
  • Defining the role of adjuvant chemotherapy after lobectomy for typical bronchopulmonary carcinoid tumors. 
  • Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness. 
  • Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. 
  • Delay from symptom onset to hospital presentation for patients with non-ST-segment elevation myocardial infarction. 
  • Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer. 
  • Delay in diagnosis and survival in testicular cancer: impact of effective therapy and changes during 18 years. 
  • Delayed percutaneous transluminal coronary angioplasty after acute myocardial infarction. 
  • Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group. 
  • Delays in fibrinolysis as primary reperfusion therapy for acute ST-segment elevation myocardial infarction. 
  • Delivery strategies to optimize resource utilization and performance status for patients with advanced life-limiting illness: results from the "palliative care trial" [ISRCTN 81117481]. 
  • Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness. 
  • Density-dependent mortality and the latitudinal gradient in species diversity. 
  • Depression and five year survival following acute myocardial infarction: a prospective study. 
  • Depression and survival following myocardial infarction. 
  • Depression as a risk factor for mortality after acute myocardial infarction. 
  • Depression in patients with coronary artery disease. 
  • Depressive symptoms and early mortality following lung transplantation: A pilot study. 
  • Depressive symptoms and mortality in lung transplant. 
  • Depressive symptoms and survival of patients with coronary artery disease. 
  • Depressive symptoms, physical activity, and clinical events: The ADAPT prospective pilot study. 
  • Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015. 
  • Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention. 
  • Design of the RELAXin in acute heart failure study. 
  • Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. 
  • Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults. 
  • Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases. 
  • Detection of previously unidentified metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic, castration resistant prostate cancer. 
  • Determinants of 15-year outcome with 1,119 standard Carpentier-Edwards porcine valves. 
  • Determinants of one-year outcome from balloon aortic valvuloplasty. 
  • Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]). 
  • Determining eligibility for lung transplantation: A nationwide assessment of the cutoff glomerular filtration rate. 
  • Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma. 
  • Development and Validation of a Mortality Prediction Model for Patients Receiving 14 Days of Mechanical Ventilation. 
  • Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients. 
  • Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network. 
  • Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic era. 
  • Development of a Congenital Heart Surgery Composite Quality Metric: Part 1-Conceptual Framework. 
  • Development of a Congenital Heart Surgery Composite Quality Metric: Part 2-Analytic Methods. 
  • Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease. 
  • Development of a quantitative donor risk index to predict short-term mortality in orthotopic heart transplantation. 
  • Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity. 
  • Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb Angioplasty Substudy. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes. 
  • Diacylglycerol kinase zeta regulates microbial recognition and host resistance to Toxoplasma gondii. 
  • Diagnosis and treatment of stage-III peripheral squamous cell carcinoma of right upper lung. 
  • Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction. 
  • Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation. 
  • Dialysis or transplantation: fitting the treatment to the patient. 
  • Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial. 
  • Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance). 
  • Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance). 
  • Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance). 
  • Differences in clinical features and in-hospital outcomes of older adults with tako-tsubo cardiomyopathy. 
  • Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction. 
  • Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer. 
  • Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. 
  • Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors. 
  • Differential outcomes with early and late repeat transplantation in the era of the lung allocation score. 
  • Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer. 
  • Differential survival with Alzheimer disease. 
  • Diffuse large B-cell lymphoma. 
  • Disappearing liver metastases: A systematic review of the current evidence. 
  • Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction. 
  • Discrete cerebral hypothermia in the management of traumatic brain injury: a randomized controlled trial. 
  • Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis. 
  • Discrimination: a new cardiovascular risk factor? 
  • Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials. 
  • Disparities in Cervical Cancer Incidence and Mortality: Can Epigenetics Contribute to Eliminating Disparities? 
  • Disparities in place of death for patients with hematological malignancies, 1999 to 2015. 
  • Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure. 
  • Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations. 
  • Distribution of survival times in a real-world cohort of older adults with chronic kidney disease: the median may not be the message. 
  • Diuretic response in acute heart failure-an analysis from ASCEND-HF. 
  • Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. 
  • Do donors matter? Short telomeres and survival after lung transplant. 
  • Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? 
  • Do patients treated at academic hospitals have better longitudinal outcomes after admission for non-ST-elevation myocardial infarction? 
  • Do the results of systematic biopsies predict outcome in patients with T1-T2 prostate cancer treated with radiation therapy alone? 
  • Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE Trial. 
  • Does Conversion in Laparoscopic Colectomy Portend an Inferior Oncologic Outcome? Results from 104,400 Patients. 
  • Does aggressive therapy improve survival in suboptimal stage IIIc/IV ovarian cancer? A Canadian-American comparative study. 
  • Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). 
  • Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer? 
  • Does perioperative systolic blood pressure variability predict mortality after cardiac surgery? An exploratory analysis of the ECLIPSE trials. 
  • Does prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer? 
  • Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? 
  • Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial. 
  • Does the multidisciplinary approach improve oncological outcomes in men undergoing surgical treatment for prostate cancer? 
  • Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma? 
  • Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study. 
  • Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index. 
  • Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group. 
  • Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation. 
  • Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer. 
  • Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study. 
  • Double negatives. 
  • Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. 
  • Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer. 
  • Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group. 
  • Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer. 
  • Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. 
  • Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial. 
  • Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery. 
  • Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. 
  • Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML. 
  • Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy. 
  • Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes. 
  • EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy. 
  • Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach. 
  • Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation. 
  • Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28. 
  • Early ovarian cancer: a review of its genetic and biologic factors, detection, and treatment. 
  • Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study. 
  • Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention. 
  • Early propranolol treatment induces lung heme-oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental sepsis. 
  • Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation. 
  • Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. 
  • Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials. 
  • Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease. 
  • Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. 
  • Echocardiographic Assessment of Right Ventricular Function and Response to Therapy in Pulmonary Arterial Hypertension. 
  • Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. 
  • Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study. 
  • Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B. 
  • Editorial Commentary: Osteochondral Lesions of the Talus: All, Nothing, or Something in Between. 
  • Editorial comment. 
  • Educational videos to reduce racial disparities in ICD therapy via innovative designs (VIVID): a randomized clinical trial. 
  • Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation. 
  • Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]). 
  • Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials. 
  • Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial. 
  • Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. 
  • Effect of Falls on Frequency of Atrial Fibrillation and Mortality Risk (from the REasons for Geographic And Racial Differences in Stroke Study). 
  • Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. 
  • Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer. 
  • Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial. 
  • Effect of Patent Foramen Ovale in Patients With Pulmonary Hypertension. 
  • Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907. 
  • Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF). 
  • Effect of Tumor Size on Risk of Metastatic Disease and Survival for Thyroid Cancer: Implications for Biopsy Guidelines. 
  • Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2). 
  • Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT). 
  • Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma. 
  • Effect of coronary artery bypass graft surgery on survival. 
  • Effect of cyclosporine on renal function in survivors of liver transplantation after 1 year. 
  • Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). 
  • Effect of dofetilide on survival in patients with supraventricular arrhythmias. 
  • Effect of health systems context on infant and child mortality in sub-Saharan Africa from 1995 to 2015, a longitudinal cohort analysis. 
  • Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. 
  • Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. 
  • Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experience. 
  • Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. 
  • Effect of machine learning methods on predicting NSCLC overall survival time based on Radiomics analysis. 
  • Effect of new disability subtype on 3-year mortality in Chinese older adults. 
  • Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults. 
  • Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION). 
  • Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer. 
  • Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research. 
  • Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. 
  • Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 
  • Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study. 
  • Effect of socioeconomic status as measured by education level on survival in breast cancer clinical trials. 
  • Effect of synthetic thymic and pineal peptides on biomarkers of ageing, survival and spontaneous tumour incidence in female CBA mice. 
  • Effect of time to surgery on outcomes in stage I esophageal adenocarcinoma. 
  • Effect of tracheostomy timing in premature infants. 
  • Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarction. 
  • Effectiveness of radiotherapy for elderly patients with anaplastic gliomas. 
  • Effectiveness of the Middle East respiratory syndrome-coronavirus protocol in enhancing the function of an Emergency Department in Qatar. 
  • Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction. 
  • Effects of a Personalized Web-Based Decision Aid for Surrogate Decision Makers of Patients With Prolonged Mechanical Ventilation: A Randomized Clinical Trial. 
  • Effects of base excision repair gene polymorphisms on pancreatic cancer survival. 
  • Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). 
  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. 
  • Effects of decreased preoperative endotoxin core antibody levels on long-term mortality after coronary artery bypass graft surgery. 
  • Effects of prices, civil and criminal sanctions, and law enforcement on alcohol-related mortality. 
  • Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer. 
  • Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). 
  • Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study. 
  • Efficacy and Safety of Low-Dose Iodine Plaque Brachytherapy for Juxtapapillary Choroidal Melanoma. 
  • Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study. 
  • Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study. 
  • Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours. 
  • Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation). 
  • Efficacy and safety of aspirin combined with warfarin after acute coronary syndrome : A meta-analysis. 
  • Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. 
  • Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma. 
  • Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3). 
  • Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. 
  • Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size. 
  • Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial. 
  • Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study. 
  • Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma. 
  • Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction. 
  • Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy. 
  • Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I. 
  • Electrical storm in patients with left ventricular assist devices: Risk factors, incidence, and impact on survival. 
  • Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial. 
  • Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes. 
  • Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone. 
  • Elevated donor hemoglobin A1c does not impair early survival in cardiac transplant recipients. 
  • Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer. 
  • Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry). 
  • Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study. 
  • Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. 
  • Emergency craniotomy for intracerebral hemorrhage: when doesn't it help and does it ever help? 
  • Emergency portacaval shunts: is Orloff correct? 
  • Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis. 
  • End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy. 
  • End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. 
  • Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia. 
  • Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. 
  • Endoscopic Resection of Sinonasal Malignancy: A Systematic Review and Meta-analysis. 
  • Endoscopic removal of metallic airway stents. 
  • Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience. 
  • Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators. 
  • Enrollment and events of hospice patients with heart failure vs. cancer. 
  • Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. 
  • Epidemiologic and survival trends in adult primary bone tumors of the spine. 
  • Epidemiologic studies targeting primary cardiovascular disease prevention in South Asia. 
  • Epidemiologic, functional, and oncologic outcome analysis of spinal sarcomas treated surgically at a single institution over 10 years. 
  • Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. 
  • Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors. 
  • Epirubicin and ifosfamide in metastatic breast cancer. 
  • Equivalent Survival Between Lobectomy and Segmentectomy for Clinical Stage IA Lung Cancer. 
  • Erythropoiesis-stimulating protein support and survival. 
  • Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. 
  • Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. 
  • Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 
  • Estimating Mortality Risk for Adult Congenital Heart Surgery: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database. 
  • Estimating lifetime risk of developing high serum total cholesterol: adjustment for baseline prevalence and single-occasion measurements. 
  • Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool. 
  • Ethyl pyruvate improves survival in awake hemorrhage. 
  • Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial. 
  • Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B study. 
  • Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study. 
  • Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. 
  • Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials. 
  • Evaluating the use and utility of noninvasive angiography in diagnosing traumatic blunt cerebrovascular injury. 
  • Evaluation and appraisal of randomized controlled trials in myeloma. 
  • Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience. 
  • Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014. 
  • Evaluation of Selvester QRS score for use in presence of conduction abnormalities in a broad population. 
  • Evaluation of a cancer survivorship protocol: transitioning patients to survivors. 
  • Evaluation of new putative tumor markers for melanoma. 
  • Evaluation of risk indices in continuous-flow left ventricular assist device patients. 
  • Evaluation of tacrolimus abbreviated area-under-the-curve monitoring in renal transplant patients who are potentially at risk for adverse events. 
  • Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial. 
  • Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas. 
  • Evaluation of the quality of care in congenital heart surgery: contribution of the Aristotle complexity score. 
  • Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group. 
  • Evidence for an immune barrier after in utero hematopoietic-cell transplantation. 
  • Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. 
  • Examining the Incidence and Presentation of Melanoma in the Cardiothoracic Transplant Population. 
  • Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis. 
  • Exercise among breast and prostate cancer survivors--what are their barriers? 
  • Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma. 
  • Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas. 
  • Expanding indications for conservative renal surgery in renal cell carcinoma. 
  • Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. 
  • Experience with 500 simultaneous pancreas-kidney transplants. 
  • Explaining the unexpected: insights from the PLATelet inhibition and clinical Outcomes (PLATO) trial comparing ticagrelor and clopidogrel. Editorial on Serebruany "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5). 
  • Exploratory thoracotomy for nonresectable lung cancer. 
  • Expression and prognostic impact of lncRNAs in acute myeloid leukemia. 
  • Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. 
  • Expression profiling of non-small cell lung carcinoma identifies metastatic genotypes based on lymph node tumor burden. 
  • Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of life. 
  • Extended hepatic resection for gallbladder cancer. 
  • Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study. 
  • Extending the boundaries of acceptable organ donors: a means of expanding the donor pool for liver transplantation. 
  • Extensive disease small cell lung cancer dose-response relationships: implications for resistance mechanisms. 
  • Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction. 
  • Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. 
  • Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. 
  • Extracorporeal life support use in pediatric trauma: a review of the National Trauma Data Bank. 
  • Extracorporeal liver perfusion using human and pig livers for acute liver failure. 
  • Extracorporeal membrane oxygenation support and post-heart transplant outcomes among United States adults. 
  • Extranodal head and neck lymphoma. Prognosis and patterns of recurrence. 
  • Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. 
  • Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer. 
  • FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer. 
  • FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma. 
  • FK 506 induction and rescue therapy in pancreas transplant recipients. 
  • FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma. 
  • FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. 
  • FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function. 
  • Factors Associated With Head and Neck Cancer Hospitalization Cost and Length of Stay-A National Study. 
  • Factors Associated With Poor Child Motor Vehicle Restraint on the USA-Mexico Border. 
  • Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. 
  • Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission. 
  • Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger. 
  • Factors associated with improved survival following surgery for renal cell carcinoma spinal metastases. 
  • Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients. 
  • Factors associated with survival in pediatric adrenocortical carcinoma: An analysis of the National Cancer Data Base (NCDB). 
  • Factors associated with survival in pediatric extracorporeal membrane oxygenation--a single-center experience. 
  • Factors associated with survival in the National Registry of Veterans with ALS. 
  • Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. 
  • Factors impacting survival in children with renal cell carcinoma. 
  • Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. 
  • Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model. 
  • Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression. 
  • Failure to Rescue Rates After Coronary Artery Bypass Grafting: An Analysis From The Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy. 
  • Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. 
  • Feasibility and safety of moderate hypothermia after massive hemispheric infarction. 
  • Females have the survival advantage in glioblastoma. 
  • Fifteen-year outcome trends for valve surgery in North America. 
  • Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. 
  • Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer. 
  • Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma. 
  • First postoperative PSA is associated with outcomes in patients with node positive prostate cancer: Results from the SEARCH database. 
  • Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial. 
  • Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial. 
  • Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patients. 
  • Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia. 
  • Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone? 
  • Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels. 
  • Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. 
  • Follow-up of patients with new cardiovascular implantable electronic devices: is adherence to the experts' recommendations associated with improved outcomes? 
  • Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients. 
  • Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432. 
  • Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy. 
  • Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis. 
  • Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study. 
  • Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. 
  • Frailty and Outcomes After Myocardial Infarction: Insights From the CONCORDANCE Registry. 
  • Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. 
  • Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States. 
  • Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. 
  • Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. 
  • Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions. 
  • Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. 
  • Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. 
  • Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. 
  • Frequent occurrence of metastatic disease in patients with renal cell carcinoma and intrahepatic or supradiaphragmatic intracaval extension treated with surgery: an outcome analysis. 
  • Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma. 
  • Functional genetic variants of RUVBL1 predict overall survival of Chinese patients with epithelial ovarian cancer. 
  • Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E. coli. 
  • Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. 
  • Galactosaemia--a controversial disorder. Screening & outcome. Ireland 1972-1992. 
  • Gamma Knife radiosurgery for brain metastases from gastrointestinal primary. 
  • Gamma-ray mutagen sensitivity and survival in patients with glioma. 
  • Gaps in referral to cardiac rehabilitation of patients undergoing percutaneous coronary intervention in the United States. 
  • Gefitinib (Iressa, ZD1839) and tyrosine kinase inhibitors: the wave of the future in cancer therapy. 
  • Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. 
  • Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study. 
  • Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes. 
  • Gender Disparities in Patients With Alcoholic Liver Disease Evaluated for Liver Transplantation. 
  • Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial). 
  • Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. 
  • Gene expression patterns that characterize advanced stage serous ovarian cancers. 
  • Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. 
  • Gene expression profiling and genetic markers in glioblastoma survival. 
  • Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. 
  • Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes. 
  • Genes, demography, and life span: the contribution of demographic data in genetic studies on aging and longevity. 
  • Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. 
  • Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC. 
  • Genetic modifiers of the Kv beta2-null phenotype in mice. 
  • Genetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL). 
  • Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. 
  • Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival. 
  • Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients. 
  • Genetic variants in the human leukocyte antigen region and survival of Chinese patients with non-small cell lung carcinoma. 
  • Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival. 
  • Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer. 
  • Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. 
  • Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC). 
  • Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens. 
  • Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. 
  • Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival. 
  • Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy. 
  • Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial). 
  • Geriatric evaluation and management units in the care of the frail elderly cancer patient. 
  • Germline mutations in PPFIBP2 are associated with lethal prostate cancer. 
  • Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer. 
  • Gestational trophoblastic disease metastatic to the central nervous system. 
  • Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. 
  • Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19-Related Disease. 
  • Global risk of coronary heart disease: assessment and application. 
  • Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. 
  • Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
  • Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer. 
  • Glycated Hemoglobin and All-Cause and Cause-Specific Mortality Among Adults With and Without Diabetes. 
  • Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure). 
  • Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma. 
  • Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine. AIDS Clinical Trials Group Protocol 043 Study Group. 
  • Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection. 
  • HIV-specific health care utilization and mortality among tuberculosis/HIV coinfected persons. 
  • HLA histocompatibility affects cardiac transplant rejection and may provide one basis for organ allocation. 
  • Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma. 
  • Haptoglobin Genotype as a Prognostic Factor for Adverse Events in Coronary Artery Bypass Surgery in Diabetic Patients. 
  • Harmonized outcome measures for use in atrial fibrillation patient registries and clinical practice: Endorsed by the Heart Rhythm Society Board of Trustees. 
  • Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics. 
  • Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data. 
  • Has there been progress in the treatment of older patients with acute myeloid leukemia? 
  • HbA 1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. 
  • Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group. 
  • Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial. 
  • Healthcare Resource Availability, Quality of Care, and Acute Ischemic Stroke Outcomes. 
  • Heart Failure "End Result Cards": Solid B. 
  • Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. 
  • Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. 
  • Heart Transplantation Survival Outcomes of HIV Positive and Negative Recipients. 
  • Heart Transplantation: An In-Depth Survival Analysis. 
  • Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. 
  • Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. 
  • Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease). 
  • Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. 
  • Hemilaryngectomy for glottic carcinoma after radiation therapy failure. 
  • Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. 
  • Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. 
  • Hepatic abscess. Changes in etiology, diagnosis, and management. 
  • Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy. 
  • Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. 
  • Hepatitis B core antibody-positive donors in cardiac transplantation: a single-center experience. 
  • Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. 
  • Hepatocellular adenoma among adult survivors of childhood and young adult cancer. 
  • Hepatocellular carcinoma in patients with no identifiable risk factors. 
  • Heterogeneity's ruses: some surprising effects of selection on population dynamics. 
  • Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. 
  • High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study. 
  • High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer. 
  • High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. 
  • High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma. 
  • High mortality rates for very low birth weight infants in developing countries despite training. 
  • High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. 
  • High oxygen prevents fetal lethality due to lack of catecholamines. 
  • High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. 
  • High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. 
  • High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer. 
  • High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team. 
  • High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma. 
  • High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. 
  • High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. 
  • High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. 
  • High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. 
  • High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234. 
  • High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. 
  • High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. 
  • High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. 
  • Higher Body Mass Index Increases Risk of HeartMate II Pump Thrombosis But Does Not Adversely Affect Long-Term Survival. 
  • Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants. 
  • Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study). 
  • Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma. 
  • Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. 
  • Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer. 
  • History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. 
  • History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. 
  • Home automated external defibrillators in a geriatric population: a brief discussion of the evidence. 
  • Home surveillance program prevents interstage mortality after the Norwood procedure. 
  • Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial. 
  • Hospital Surgical Volume and Associated Postoperative Complications of Pediatric Urological Surgery in the United States. 
  • Hospital variability of out-of-hospital cardiac arrest survival. 
  • Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines. 
  • Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. 
  • How long did their hearts go on? A Titanic study. 
  • How much do we gain by reducing time to reperfusion therapy? 
  • How the effects of aging and stresses of life are integrated in mortality rates: insights for genetic studies of human health and longevity. 
  • Hybrid Palliation: Outcomes After the Comprehensive Stage 2 Procedure. 
  • Hyperimmune human IgG or recombinant human granulocyte-macrophage colony-stimulating factor as adjunctive therapy for group B streptococcal sepsis in newborn rats. 
  • Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms. 
  • Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy. 
  • Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. 
  • Hypothermia and cerebral protection strategies in aortic arch surgery: a comparative effectiveness analysis from the STS Adult Cardiac Surgery Database. 
  • IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas. 
  • IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. 
  • ISIS-4. 
  • Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. 
  • Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial. 
  • Identification of poorly performing transplant centers using the UNOS center-specific data. 
  • Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. 
  • Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. 
  • Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. 
  • Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses. 
  • Imaging descriptors improve the predictive power of survival models for glioblastoma patients. 
  • Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. 
  • Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909. 
  • Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. 
  • Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma. 
  • Immunotherapy for malignant melanoma with a tumor cell vaccine. 
  • Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma. 
  • Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer. 
  • Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. 
  • Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer. 
  • Impact of Atrial Fibrillation on In-Hospital Mortality and Thromboembolic Complications after Left Ventricular Assist Device Implantation. 
  • Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study. 
  • Impact of Donor Brain Death Duration on Outcomes After Lung Transplantation. 
  • Impact of Early-Onset Sepsis and Antibiotic Use on Death or Survival with Neurodevelopmental Impairment at 2 Years of Age among Extremely Preterm Infants. 
  • Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry. 
  • Impact of Micro- and Macroscopically Positive Surgical Margins on Survival after Resection of Adrenocortical Carcinoma. 
  • Impact of Positive Margins and Radiation After Tracheal Adenoid Cystic Carcinoma Resection on Survival. 
  • Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients. 
  • Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer. 
  • Impact of Pulmonary Hypertension on Survival Following Device Closure of Atrial Septal Defects. 
  • Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer. 
  • Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival. 
  • Impact of Tachyarrhythmia Detection Rate and Time from Detection to Shock on Outcomes in Nationwide US Practice. 
  • Impact of Timeliness of Resection and Thyroidectomy Margin Status on Survival for Patients with Anaplastic Thyroid Cancer: An Analysis of 335 Cases. 
  • Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma. 
  • Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care. 
  • Impact of anemia on mortality, cognition, and function in community-dwelling elderly. 
  • Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. 
  • Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. 
  • Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005. 
  • Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. 
  • Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR). 
  • Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. 
  • Impact of donor and recipient age difference on long-term allograft survival after living donor renal transplantation: analysis of 478 cases. 
  • Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. 
  • Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation: an individual patient data meta-analysis of randomised trials. 
  • Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. 
  • Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. 
  • Impact of fibrinogen levels on angiographic progression and 12-year survival in the armed forces regression study. 
  • Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). 
  • Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). 
  • Impact of home warfarin use on the treatment and outcomes of patients undergoing percutaneous coronary intervention. 
  • Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. 
  • Impact of lipid-lowering medications and low-density lipoprotein levels on 1-year clinical outcomes after coronary artery bypass grafting. 
  • Impact of marital status in patients undergoing radical cystectomy for bladder cancer. 
  • Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma. 
  • Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy). 
  • Impact of number of nodes retrieved on outcome in patients with rectal cancer. 
  • Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. 
  • Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association. 
  • Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM. 
  • Impact of preoperative chronic lung disease on survival after surgical aortic valve replacement. 
  • Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. 
  • Impact of radical prostatectomy in the management of clinically localized disease. 
  • Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting. 
  • Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. 
  • Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters. 
  • Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina. 
  • Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial. 
  • Impact of specific postoperative complications on the outcomes of emergency general surgery patients. 
  • Impact of the lung allocation score on survival beyond 1 year. 
  • Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. 
  • Impact of the three COVID-19 surges in 2020 on in-hospital cardiac arrest survival in the United States. 
  • Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma. 
  • Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. 
  • Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction. 
  • Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). 
  • Implantable cardioverter defibrillators: risks accompany the life-saving benefits. 
  • Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions. 
  • Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes. 
  • Implantable left ventricular assist devices: new hope for patients with end-stage heart failure. 
  • Implementation of a National 5-Year Plan for Prehospital Emergency Care in Singapore and Impact on Out-of-Hospital Cardiac Arrest Outcomes From 2011 to 2016. 
  • Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients. 
  • Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF). 
  • Implications of a recurrent in-hospital cardiac arrest on survival and neurological outcomes. 
  • Implications of blood group on lung transplantation rates: A propensity-matched registry analysis. 
  • Implications of declining donor offers with increased risk of disease transmission on waiting list survival in lung transplantation. 
  • Implications of peritoneal cytology for pancreatic cancer management. 
  • Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. 
  • Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. 
  • Important impact of gingival and periodontal conditions on outcomes in SCT recipients. 
  • Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial. 
  • Improved early survival with a nonsternotomy approach for continuous-flow left ventricular assist device replacement. 
  • Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. 
  • Improved outcome in central nervous system aspergillosis, using voriconazole treatment. 
  • Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing. 
  • Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up. 
  • Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. 
  • Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. 
  • Improved survival in advanced Hodgkin's disease with the use of combined modality therapy. 
  • Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation. 
  • Improved survival rates in sebaceous carcinoma of the eyelid. 
  • Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. 
  • Improvement in Liver Transplant Outcomes From Older Donors: A US National Analysis. 
  • Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. 
  • Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy. 
  • Improving Care of STEMI in the United States 2008 to 2012. 
  • Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy. 
  • Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group. 
  • Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. 
  • Improving the quality of survivorship for older adults with cancer. 
  • In hormone-naive metastatic prostate cancer, should all patients now receive docetaxel? No, not yet. 
  • In situ bypass and extra-anatomic bypass procedures result in similar survival in patients with secondary aortoenteric fistulas. 
  • In the face of chronic aspiration, prolonged ischemic time exacerbates obliterative bronchiolitis in rat pulmonary allografts. 
  • In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299. 
  • In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. 
  • In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma. 
  • In-Hospital Cardiac Arrest Survival in the United States During and After the Initial Novel Coronavirus Disease 2019 Pandemic Surge. 
  • In-Hospital and Three-Year Outcomes of Heart Failure Patients in South India: The Trivandrum Heart Failure Registry. 
  • In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score. 
  • Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy. 
  • Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population. 
  • Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries. 
  • Incidence and long-term significance of transient ST segment deviation in hemodialysis patients. 
  • Incidence and predictors of sudden cardiac death in patients with diastolic heart failure. 
  • Incidence and prevalence of heart failure in elderly persons, 1994-2003. 
  • Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study). 
  • Incidence and survival rates for young blacks with nasopharyngeal carcinoma in the United States. 
  • Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report. 
  • Incidence of heart failure and mortality after acute coronary syndromes. 
  • Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome. 
  • Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry. 
  • Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study. 
  • Incidental thyroid nodules on CT: evaluation of 2 risk-categorization methods for work-up of nodules. 
  • Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches. 
  • Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys. 
  • Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma. 
  • Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. 
  • Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial. 
  • Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. 
  • Increasing rates of dementia at time of declining mortality from stroke. 
  • Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe? 
  • Independent predictors for local recurrence following surgery for spinal metastasis. 
  • Indications for adjuvant radiotherapy in extrapelvic colonic carcinoma. 
  • Individual aging and mortality rate: how are they related? 
  • Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma. 
  • Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer. 
  • Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. 
  • Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281). 
  • Infant pediatric liver transplantation results equal those for older pediatric patients. 
  • Infected joint replacements in HIV-positive patients with haemophilia. 
  • Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view. 
  • Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. 
  • Infections in patients with cystic fibrosis following lung transplantation. 
  • Inflammation and the paradox of racial differences in dialysis survival. 
  • Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome. 
  • Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction. 
  • Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease. 
  • Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial. 
  • Influence of donor brain death duration on outcomes following heart transplantation: A United Network for Organ Sharing Registry analysis. 
  • Influence of gestational age on death and neurodevelopmental outcome in premature infants with severe intracranial hemorrhage. 
  • Influence of global region on outcomes in heart failure β-blocker trials. 
  • Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction. 
  • Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1. 
  • Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. 
  • Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. 
  • Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management. 
  • Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. 
  • Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. 
  • Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. 
  • Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non-ST-segment elevation myocardial infarction. 
  • Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. 
  • Influence of smoking history on imaging characteristics among patients with human papillomavirus-positive oropharyngeal cancer: a blinded matched-pair analysis. 
  • Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration. 
  • Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial. 
  • Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells. 
  • Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies. 
  • Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States. 
  • Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial. 
  • Initial Laparotomy Versus Peritoneal Drainage in Extremely Low Birthweight Infants With Surgical Necrotizing Enterocolitis or Isolated Intestinal Perforation: A Multicenter Randomized Clinical Trial. 
  • Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy. 
  • Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing program. 
  • Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction. 
  • Innate immunity influences long-term outcomes after human lung transplant. 
  • Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial. 
  • Insulin and longevity: antidiabetic biguanides as geroprotectors. 
  • Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction. 
  • Insurance and education predict long-term survival after orthotopic heart transplantation in the United States. 
  • Insurance status, stage of presentation, and survival among female patients with head and neck cancer. 
  • Integrated genomic analyses in bronchopulmonary dysplasia. 
  • Integrated genomic analysis of survival outliers in glioblastoma. 
  • Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. 
  • Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution. 
  • Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. 
  • Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE). 
  • Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. 
  • Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. 
  • Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis. 
  • Internal mammary artery graft angioplasty: acute and long-term outcome. 
  • International differences in evolution of early discharge after acute myocardial infarction. 
  • Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. 
  • Intervening on small infarct-related arteries: what does the future hold? 
  • Intervention for recoarctation in the single ventricle reconstruction trial: incidence, risk, and outcomes. 
  • Interventional strategies associated with improvements in survival for out-of-hospital cardiac arrests in Singapore over 10 years. 
  • Interventions to Reduce Personal Exposures to Air Pollution: A Primer for Health Care Providers. 
  • Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001. 
  • Intestinal transplantation: a single-center experience. 
  • Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma. 
  • Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes. 
  • Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator. 
  • Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes. 
  • Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases. 
  • Intraoperatic electron beam irradiation in pancreatic cancer. 
  • Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. 
  • Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma. 
  • Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma. 
  • Intraoperative pulmonary artery stenting: an alternative technique for the management of pulmonary artery stenosis. 
  • Intraoperative radiation therapy. 
  • Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. 
  • Intraparenchymal vs extracranial ventricular drain intracranial pressure monitors in traumatic brain injury: less is more? 
  • Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis. 
  • Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B. 
  • Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia. 
  • Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus. 
  • Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. 
  • Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. 
  • Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death. 
  • Introduction. 
  • Introduction: The science of survivorship: moving from risk to risk reduction. 
  • Introduction: current controversies in rectal cancer. 
  • Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. 
  • Investigating confounders of the association between survival and adjuvant radiation therapy after breast conserving surgery in a sample of elderly breast Cancer patients in Appalachia. 
  • Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. 
  • Invited commentary. 
  • Invited commentary. 
  • Invited commentary: (Mass) Imprisonment and (Inequities in) Health. 
  • Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. 
  • Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma. 
  • Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis. 
  • Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus? A Contemporary View from the NCDB. 
  • Is body mass index a risk factor for isolated off-pump coronary revascularization? 
  • Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial. 
  • Is port site resection necessary in the surgical management of gallbladder cancer? 
  • Is specialty care associated with improved survival of patients with congestive heart failure? 
  • Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? 
  • Is there a role for survivorship care plans in advanced cancer? 
  • Ischemic nephropathy and concomitant aortic disease: a ten-year experience. 
  • Isolated liver transplantation in infants with total parenteral nutrition-associated end-stage liver disease. 
  • Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. 
  • Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). 
  • LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. 
  • Lack of Association Between Heart Failure and Incident Cancer. 
  • Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. 
  • Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation. 
  • Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B. 
  • Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature. 
  • Laparoscopic biliary and enteric bypass. 
  • Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes. 
  • Laparoscopic versus open Hartmann procedure for the emergency treatment of diverticulitis: a propensity-matched analysis. 
  • Laparoscopic versus open donor nephrectomy: comparing ureteral complications in the recipients and improving the laparoscopic technique. 
  • Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN): 12-Month Outcomes and Quality of Life After Brain Tumor Ablation. 
  • Late Effects of Exposure to Ionizing Radiation and Age on Human Thymus Morphology and Function. 
  • Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults. 
  • Late Health Outcomes After Contemporary Lymphome Malin de Burkitt Therapy for Mature B-Cell Non-Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study. 
  • Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. 
  • Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor Study. 
  • Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. 
  • Late graft loss and long-term outcome after isolated intestinal transplantation in children. 
  • Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. 
  • Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. 
  • Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. 
  • Left ventricular assist devices versus medical management in ambulatory heart failure patients: An analysis of INTERMACS Profiles 4 and 5 to 7 from the ROADMAP study. 
  • Leiomyosarcoma in childhood and adolescence. 
  • Lentigo maligna melanoma of the head and neck. 
  • Letter by Bourque et al regarding article, "Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994". 
  • Letter by Hill et al. regarding article, "Mortality in first 5 years in infants with functional single ventricle born in Texas, 1996 to 2003". 
  • Leukemia: an overview for primary care. 
  • Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. 
  • Level and Change in N-Terminal Pro-B-Type Natriuretic Peptide and Kidney Function and Survival to Age 90. 
  • Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues. 
  • Limited health literacy and adverse outcomes among kidney transplant candidates. 
  • Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence. 
  • Liver and intestine transplantation in the United States 1998-2007. 
  • Liver function tests: inadequate screening modality for detection of liver metastasis in head and neck carcinoma. 
  • Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study. 
  • Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy. 
  • Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades. 
  • Liver transplantation at the University of Wisconsin. 
  • Liver transplantation in pediatric patients: twenty years of experience at the University of Wisconsin. 
  • Living related donor liver transplantation at the University of Nebraska Medical Center (1996). 
  • Living unrelated renal donation: the University of Wisconsin experience. 
  • Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria. 
  • Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. 
  • Local excision results in comparable survival to radical resection for early-stage rectal carcinoid. 
  • Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. 
  • Local therapy for rhabdomyosarcoma of the hands and feet: is amputation necessary? A report from the Children's Oncology Group. 
  • Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy. 
  • Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis. 
  • Locally advanced (high-risk) prostate cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Locally unresectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. 
  • Log-Rank Test vs MaxCombo and Difference in Restricted Mean Survival Time Tests for Comparing Survival Under Nonproportional Hazards in Immuno-oncology Trials: A Systematic Review and Meta-analysis. 
  • Long term outcome of blunt trauma care in the elderly. 
  • Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis. 
  • Long-Term Outcomes of 125 Patients With Metastatic Pheochromocytoma or Paraganglioma Treated With 131-I MIBG. 
  • Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment. 
  • Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac Arrest. 
  • Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter? 
  • Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases. 
  • Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device. 
  • Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer. 
  • Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis. 
  • Long-term follow-up after uveal melanoma charged particle therapy. 
  • Long-term follow-up of auxiliary orthotopic liver transplantation for the treatment of fulminant hepatic failure. 
  • Long-term follow-up of patients with advanced ovarian carcinoma treated with debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide. Gynecologic Oncology Group of the Comprehensive Cancer Center. 
  • Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. 
  • Long-term follow-up of pediatric head trauma patients treated at Mulago National Referral Hospital in Uganda. 
  • Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment. 
  • Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. 
  • Long-term mortality in patients with pauses in ventricular electrical activity. 
  • Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. 
  • Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study. 
  • Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. 
  • Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients. 
  • Long-term outcome after marrow transplantation for severe aplastic anemia. 
  • Long-term outcome after pulmonary thromboendarterectomy. 
  • Long-term outcome and impact of surgery on adults with coronary arteries originating from the opposite coronary cusp. 
  • Long-term outcomes after isolated aortic valve replacement in octogenarians: a modern perspective. 
  • Long-term outcomes and management of the heart transplant recipient. 
  • Long-term outcomes following development of new-onset atrial fibrillation during sepsis. 
  • Long-term outcomes in elderly survivors of in-hospital cardiac arrest. 
  • Long-term outcomes in simultaneous kidney-pancreas transplant recipients. 
  • Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure. 
  • Long-term outcomes of mitral regurgitation by type and severity. 
  • Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. 
  • Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL. 
  • Long-term outcomes of thoracoscopic lobectomy. 
  • Long-term prognostic implications of sex-steroid receptors in human cancer. 
  • Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). 
  • Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. 
  • Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05). 
  • Long-term results of intestinal transplantation for pseudo-obstruction in children. 
  • Long-term results of liver transplantation in older patients 60 years of age and older. 
  • Long-term sequelae following median sternotomy wound infection and flap reconstruction. 
  • Long-term survival after aortic valve replacement among high-risk elderly patients in the United States: insights from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 1991 to 2007. 
  • Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. 
  • Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the unos registry. 
  • Long-term survival for patients with preoperative renal failure undergoing bioprosthetic or mechanical valve replacement. 
  • Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. 
  • Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial. 
  • Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. 
  • Longitudinal Patterns of Change in Systolic Blood Pressure and Incidence of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. 
  • Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry. 
  • Longitudinal associations between BMI change and the risks of colorectal cancer incidence, cancer-relate and all-cause mortality among 81,388 older adults : BMI change and the risks of colorectal cancer incidence and mortality. 
  • Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. 
  • Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02). 
  • Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007. 
  • Longitudinal study of anthropometry in Fontan survivors: Pediatric Heart Network Fontan study. 
  • Longterm followup and quality of life after hematopoietic stem cell transplantation. 
  • Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION. 
  • Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers. 
  • Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance. 
  • Low heart rate variability and the effect of depression on post-myocardial infarction mortality. 
  • Low plasma concentrations of retinol and alpha-tocopherol in hematopoietic stem cell transplant recipients: the effect of mucositis and the risk of infection. 
  • Low volume is associated with worse patient outcomes for pediatric liver transplant centers. 
  • Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. 
  • Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720. 
  • Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology. 
  • Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality. 
  • Lung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants. 
  • Lung cancer and positron emission tomography with fluorodeoxyglucose. 
  • Lung transplantation after long-term mechanical ventilation : results and 1-year follow-up. 
  • Lung transplantation at Duke University Medical Center. 
  • Lung transplantation using allografts with more than 8 hours of ischemic time: A single-institution experience. 
  • Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy. 
  • Lysyl oxidase is essential for hypoxia-induced metastasis. 
  • MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation. 
  • MDM4 genetic variants and risk of gastric cancer in an Eastern Chinese population. 
  • MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group. 
  • MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. 
  • MRP3: a molecular target for human glioblastoma multiforme immunotherapy. 
  • MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation. 
  • MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. 
  • Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients. 
  • Magnetic compression anastomosis (magnamosis) in a porcine esophagus: Proof of concept for potential application in esophageal atresia. 
  • Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677. 
  • Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance). 
  • Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study. 
  • Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. 
  • Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. 
  • Making genuine progress against metastatic breast cancer. 
  • Malignant brainstem gliomas in adults: clinicopathological characteristics and prognostic factors. 
  • Malignant glioma--timing of response to radiation therapy. 
  • Malignant gliomas in older adults with poor prognostic signs. Getting nowhere, and taking a long time to do it. 
  • Malignant melanoma and pregnancy. 
  • Malignant melanoma in black Americans. A trend toward improved survival. 
  • Malignant melanoma in children. 
  • Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. 
  • Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review. 
  • Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. 
  • Malignant struma ovarii: a population-level analysis of a large series of 68 patients. 
  • Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry. 
  • Management and long-term outcome of aortic dissection. 
  • Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry. 
  • Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. 
  • Management of Pregnancy and Survival of Infants with Trisomy 13 or Trisomy 18. 
  • Management of abdominal aortic graft complications. 
  • Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies. 
  • Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? 
  • Management of gastrointestinal bleeding in patients with cirrhosis. 
  • Management of glioblastoma: State of the art and future directions. 
  • Management of infrainguinal occluded vein bypasses with a combined approach of thrombolysis and surveillance. A prospective study. 
  • Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Mangroves protected villages and reduced death toll during Indian super cyclone. 
  • Marital status improves survival after orthotopic heart transplantation. 
  • Marital status independently predicts testis cancer survival--an analysis of the SEER database. 
  • Marrow transplant experience for children with severe aplastic anemia. 
  • Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. 
  • Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. 
  • Massive soft tissue infections: necrotizing fasciitis and purpura fulminans. 
  • Massive transfusion exceeding 50 units of blood products in trauma patients. 
  • Matched analysis of survival in patients with squamous cell carcinoma of the head and neck diagnosed before and after 40 years of age. 
  • Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. 
  • Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. 
  • Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. 
  • Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy. 
  • Measurement of progress against cancer. Extramural Committee to Assess Measures of Progress Against Cancer. 
  • Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). 
  • Measures of cardiac repolarization and body position in infants. 
  • Measuring hospital mortality rates: are 30-day data enough? Ischemic Heart Disease Patient Outcomes Research Team. 
  • Measuring the effectiveness of medical care delivery. 
  • Mechanical calf compression and aspirin prophylaxis for total knee arthroplasty. 
  • Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI). 
  • Mechanically ventilated pediatric stem cell transplant recipients: effect of cord blood transplant and organ dysfunction on outcome. 
  • Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. 
  • Medication adherence: a call for action. 
  • Medication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction. 
  • Meeting the challenge to improve the treatment of hypertension in blacks. 
  • Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. 
  • Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. 
  • Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras. 
  • Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. 
  • Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. 
  • Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. 
  • Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions. 
  • Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database. 
  • Metastatic adenocarcinoma to the neck from an unknown primary source. 
  • Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results. 
  • Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer. 
  • Methods to assess adverse health-related outcomes in cancer survivors. 
  • MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer. 
  • Midterm results for endovascular repair of complicated acute and chronic type B aortic dissection. 
  • Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry. 
  • Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial). 
  • Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma. 
  • Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical Outcomes From The Society of Thoracic Surgeons National Database. 
  • Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis. 
  • Minimally Invasive Versus Open Low Anterior Resection: Equivalent Survival in a National Analysis of 14,033 Patients With Rectal Cancer. 
  • Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? 
  • Minority adult survivors of childhood cancer: a comparison of long-term outcomes, health care utilization, and health-related behaviors from the childhood cancer survivor study. 
  • Mitral Regurgitation After Orthotopic Lung Transplantation: Natural History and Impact on Outcomes. 
  • Mitral gradients and frequency of recurrence of mitral regurgitation after ring annuloplasty for ischemic mitral regurgitation. 
  • Mitral valve repair for degenerative disease: a 20-year experience. 
  • Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients. 
  • Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence. 
  • Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma. 
  • Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia. 
  • Modulation of specific active immunization against murine melanoma using recombinant cytokines. 
  • Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. 
  • Molecular biologic substaging of stage I lung cancer according to gender and histology. 
  • Molecular markers of therapeutic resistance in breast cancer. 
  • Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial. 
  • Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience. 
  • Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker. 
  • Morbidity and mortality in the surgical treatment of six hundred five pediatric patients with isthmic or dysplastic spondylolisthesis. 
  • Morbidity, mortality, and weight loss outcomes after reoperative bariatric surgery in the USA. 
  • More on the GUSTO trial. 
  • More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia. 
  • Morning and Evening Home Blood Pressure and Risks of Incident Stroke and Coronary Artery Disease in the Japanese General Practice Population: The Japan Morning Surge-Home Blood Pressure Study. 
  • Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults. 
  • Morphomics predicts response to ipilimumab in patients with stage IV melanoma. 
  • Mortality among heroin users and users of other internationally regulated drugs: A 27-year follow-up of users in the Epidemiologic Catchment Area Program household samples. 
  • Mortality and Respiratory Failure After Thoracoscopic Lung Biopsy for Interstitial Lung Disease. 
  • Mortality and follow-up colonoscopy after colorectal cancer. 
  • Mortality and need for reoperation in patients with mild-to-moderate asymptomatic aortic valve disease undergoing coronary artery bypass graft alone. 
  • Mortality and neurodevelopmental outcome after Staphylococcus aureus bacteremia in infants. 
  • Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias. 
  • Mortality in primary and secondary myocarditis. 
  • Mortality risk associated with ejection fraction differs across resting nuclear perfusion findings. 
  • Mortality trends associated with acute renal failure requiring dialysis after CABG surgery in the United States. 
  • Mortality versus survival graphs: improving temporal consistency in perceptions of treatment effectiveness. 
  • Mortality with percutaneous endoscopic gastrostomy. 
  • Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. 
  • Multi-ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF-ACTION trial and the ASIAN-HF registry. 
  • Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors. 
  • Multicenter Analysis of Early Childhood Outcomes After Repair of Truncus Arteriosus. 
  • Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol. 
  • Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer. 
  • Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer. 
  • Multimodality management of locally advanced rectal cancer. 
  • Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure. 
  • Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. 
  • Multiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase--a key enzyme in lacto-neolacto ganglioside synthesis. 
  • Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer. 
  • Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction. 
  • Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. 
  • Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study. 
  • Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas. 
  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. 
  • Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation. 
  • Myocarditis and long-term survival in peripartum cardiomyopathy. 
  • Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases. 
  • Myonecrosis after revascularization procedures. 
  • NCCN Guidelines Insights: Bone Cancer, Version 2.2017. 
  • NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016. 
  • NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. 
  • NCCN Guidelines Insights: Survivorship, Version 1.2016. 
  • Nasopharyngeal carcinoma in young patients: a systematic review of racial demographics. 
  • National estimations of airway foreign bodies in children in the United States, 2000 to 2009. 
  • National inpatient complications and outcomes after surgery for spinal metastasis from 1993-2002. 
  • Natriuretic peptides and long-term mortality in patients with severe aortic stenosis. 
  • Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. 
  • Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. 
  • Natural history of renal cell carcinoma. 
  • Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. 
  • Negative T waves shortly after ST-elevation acute myocardial infarction are a powerful marker for improved survival rate. 
  • Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma. 
  • Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. 
  • Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer. 
  • Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. 
  • Neoadjuvant hormone therapy: the Canadian trials. 
  • Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer. 
  • Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer. 
  • Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. 
  • Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. 
  • Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. 
  • Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. 
  • Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. 
  • Neurodevelopmental outcome of infants with unilateral or bilateral periventricular hemorrhagic infarction. 
  • Neurointerventional procedures for unruptured intracranial aneurysms under procedural sedation and local anesthesia: a large-volume, single-center experience. 
  • Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor. 
  • New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials. 
  • New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. 
  • New therapeutic options in the management of childhood brain tumors. 
  • Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057). 
  • Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial. 
  • Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. 
  • Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial. 
  • No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial. 
  • Nocturnal patterns of heart rate and the risk of mortality after acute myocardial infarction. 
  • Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935. 
  • Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT. 
  • Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial Fibrillation. 
  • Non-immune hydrops after 20 weeks' gestation: review of 10 years' experience with suggestions for management. 
  • Non-invasive risk assessment in patients with chronic kidney disease. 
  • Nondisease-specific problems and all-cause mortality in the REasons for Geographic and Racial Differences in Stroke study. 
  • Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study Group. 
  • Nonlymphoblastic lymphoma in children--histology and stage-related response to therapy: a Pediatric Oncology Group study. 
  • Nonparametric inference on median residual life function. 
  • Norwood reconstruction using continuous coronary perfusion: a safe and translatable technique. 
  • Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction. 
  • Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study. 
  • Novel functional variants in the Notch pathway and survival of Chinese colorectal cancer. 
  • Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results. 
  • Novel prognostic markers for patients with triple-negative breast cancer. 
  • Nucleotide excision repair genes are expressed at low levels and are not detectably inducible in Caenorhabditis elegans somatic tissues, but their function is required for normal adult life after UVC exposure 
  • Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status. 
  • Obesity and long-term clinical and economic outcomes in coronary artery disease patients. 
  • Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer. 
  • Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. 
  • Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study. 
  • Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial. 
  • Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry. 
  • Off-Pump Versus On-Pump Impact: Diabetic Patient 5-Year Coronary Artery Bypass Clinical Outcomes. 
  • Off-pump coronary artery bypass disproportionately benefits high-risk patients. 
  • Off-study utilization of experimental therapies: Analysis of GOG249-eligible cohorts using real world data. 
  • On sample size calculation for comparing survival curves under general hypothesis testing. 
  • On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension. 
  • One thousand liver transplants. The lessons learned. 
  • One-unit versus two-unit cord-blood transplantation for hematologic cancers. 
  • One-year follow-up of the ASSENT-2 trial: a double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction. 
  • One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trial. 
  • Open versus endovascular repair of ruptured abdominal aortic aneurysms. 
  • Opportunities for improving use of evidence-based therapy in patients with type 2 diabetes and cardiovascular disease. 
  • Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years? 
  • Optimal two-stage log-rank test for randomized phase II clinical trials. 
  • Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate. 
  • Oral primary care: an analysis of its impact on the incidence and mortality rates of oral cancer. 
  • Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience. 
  • Osteogenic sarcoma of the head and neck. The UCLA experience. 
  • Osteoporosis in lung transplant candidates compared to matched healthy controls. 
  • Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients. 
  • Outcome and prognostic factors after adrenalectomy for patients with distant adrenal metastasis. 
  • Outcome and prognostic factors in adult cerebellar glioblastoma. 
  • Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). 
  • Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). 
  • Outcome of lung transplant patients admitted to the medical ICU. 
  • Outcome of lung transplantation in patients with mycetomas. 
  • Outcome profiles of locoregional disease after radical prostatectomy and radiotherapy. 
  • Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry. 
  • Outcomes Among Patients Transferred for Revascularization With Impella for Acute Myocardial Infarction With Cardiogenic Shock from the cVAD Registry. 
  • Outcomes Associated With Extraction Versus Capping and Abandoning Pacing and Defibrillator Leads. 
  • Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. 
  • Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia. 
  • Outcomes after coronary artery bypass grafting in patients with myocardial infarction, cardiogenic shock and unresponsive neurological state: analysis of the Society of Thoracic Surgeons Database. 
  • Outcomes after massive transfusion in nontrauma patients in the era of damage control resuscitation. 
  • Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B. 
  • Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients. 
  • Outcomes and predictors of survival in cutaneous melanoma of the eyelid: An analysis of the National Cancer Database. 
  • Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. 
  • Outcomes by race and etiology of patients with left ventricular systolic dysfunction. 
  • Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). 
  • Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter. 
  • Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents. 
  • Outcomes in Kidney Transplantation Between Veterans Affairs and Civilian Hospitals: Considerations in the Context of the MISSION Act. 
  • Outcomes in a series of 103 retroperitoneal sarcomas. 
  • Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. 
  • Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank. 
  • Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors. 
  • Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database. 
  • Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study. 
  • Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. 
  • Outcomes of Severely Obese Patients Supported by a Centrifugal-Flow Left Ventricular Assist Device. 
  • Outcomes of acute type a dissection repair before and after implementation of a multidisciplinary thoracic aortic surgery program. 
  • Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. 
  • Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials. 
  • Outcomes of high-risk acute promyelocytic leukemia patients treated with arsenic trioxide (ATO)/all trans retinoic acid (ATRA) based induction and consolidation without maintenance phase: A case Series. 
  • Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial). 
  • Outcomes of laparoscopic resection of Meckel's diverticulum are equivalent to open laparotomy. 
  • Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. 
  • Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. 
  • Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry). 
  • Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant. 
  • Outcomes of primary repair and primary anastomosis in war-related colon injuries. 
  • Outcomes of repair of common arterial trunk with truncal valve surgery: a review of the society of thoracic surgeons congenital heart surgery database. 
  • Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy. 
  • Outcomes of surgical revascularization for lower extremity arterial thromboembolism in patients with advanced malignancy. 
  • Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). 
  • Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. 
  • Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC. 
  • Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH. 
  • Overdiagnosis in low-dose computed tomography screening for lung cancer. 
  • Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas. 
  • Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer. 
  • Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. 
  • P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808. 
  • PD-L1 Expression Correlates With Young Age and CD8+ TIL Density in Poorly Differentiated Cervical Squamous Cell Carcinoma. 
  • PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions. 
  • PET-based primary tumor volumetric parameters and survival of patients with non-small cell lung carcinoma. 
  • PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study. 
  • PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. 
  • Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer. 
  • Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532. 
  • Painless exercise ST deviation on the treadmill: long-term prognosis. 
  • Palliative treatment of rectal cancer: is radiotherapy alone a good option? 
  • Pancreas transplantation at the University of Maryland. 
  • Pancreas transplantation at the University of Wisconsin. 
  • Pancreas transplantation: the Nebraska experience. 
  • Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis. 
  • Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors. 
  • Pancreatic adenocarcinoma: the actual 5-year survivors. 
  • Pancreatitis complicated by gland necrosis: evolution of findings on contrast-enhanced CT. 
  • Paraganglioma of the head and neck: long-term local control with radiotherapy. 
  • Paranasal sinus malignancies: an 18-year single institution experience. 
  • Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response. 
  • Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review. 
  • Partitioning of time trends in prevalence and mortality of bladder cancer in the United States. 
  • Partitioning of time trends in prevalence and mortality of lung cancer. 
  • Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT. 
  • Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. 
  • Pathogenesis of pneumococcal pneumonia in cyclophosphamide-induced leukopenia in mice. 
  • Pathologic Factors Affecting Colorectal Cancer Survival in a Jamaican Population-the UHWI Experience. 
  • Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients. 
  • Pathologic response after neoadjuvant carboplatin and weekly paclitaxel for early-stage lung cancer: a Brown University oncology group phase II study. 
  • Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. 
  • Pathophysiology and management of life-threatening asthma. 
  • Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT). 
  • Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. 
  • Patient and provider preferences for survivorship care plans. 
  • Patient education: recommendations regarding sunscreens, drugs, and diet. 
  • Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability. 
  • Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment. 
  • Patient selection for mechanical circulatory support. 
  • Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation. 
  • Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®. 
  • Patient-Centered Measures of Treatment Benefit. 
  • Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management). 
  • Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial. 
  • Patients Treated at Low-Volume Centers have Higher Rates of Incomplete Resection and Compromised Outcomes: Analysis of 31,129 Patients with Papillary Thyroid Cancer. 
  • Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial. 
  • Patients with DNR orders in the operating room: surgery, resuscitation, and outcomes. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. 
  • Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. 
  • Pattern of failure in anaplastic glioma patients with an IDH1/2 mutation. 
  • Patterns and predictors of smoking cessation in an elderly cohort. 
  • Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978. 
  • Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. 
  • Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma. 
  • Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer. 
  • Patterns of Mechanical Inefficiency in Pediatric Dilated Cardiomyopathy and Their Relation to Left Ventricular Function and Clinical Outcomes. 
  • Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort. 
  • Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. 
  • Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma. 
  • Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. 
  • Patterns of recurrence after ablation of colorectal cancer liver metastases. 
  • Patterns of recurrence following complete response to regional chemotherapy for in-transit melanoma. 
  • Patterns of recurrence of colorectal cancer. 
  • Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series. 
  • Patterns of use and outcomes of sentinel lymph node mapping for patients with high-grade endometrial cancer. 
  • Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. 
  • Pediatric Acute Respiratory Distress Syndrome in Pediatric Allogeneic Hematopoietic Stem Cell Transplants: A Multicenter Study. 
  • Pediatric melanoma: a single-institution experience of 150 patients. 
  • Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. 
  • Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases. 
  • Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. 
  • Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. 
  • Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. 
  • Performance measures to promote quality improvement in sudden cardiac arrest prevention and treatment. 
  • Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years. 
  • Performing Concomitant Tricuspid Valve Repair at the Time of Mitral Valve Operations Is Not Associated With Increased Operative Mortality. 
  • Periannular complications in infective endocarditis involving prosthetic aortic valves. 
  • Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. 
  • Perioperative Implications of End-stage Renal Disease in Orthopaedic Surgery. 
  • Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. 
  • Perioperative management of special populations: immunocompromised host (cancer, HIV, transplantation). 
  • Perioperative morbidity and mortality in combined vs. staged approaches to carotid and coronary revascularization. 
  • Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations. 
  • Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer. 
  • Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). 
  • Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure. 
  • Peritumoral expression of adipokines and fatty acids in breast cancer. 
  • Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry. 
  • Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer. 
  • Persistent diarrhoea in Nigerian children aged less than five years: a hospital-based study. 
  • Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas. 
  • Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes. 
  • Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. 
  • Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103. 
  • Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer. 
  • Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. 
  • Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors. 
  • Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. 
  • Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103). 
  • Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. 
  • Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. 
  • Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. 
  • Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM). 
  • Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma. 
  • Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma. 
  • Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer. 
  • Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). 
  • Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. 
  • Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme. 
  • Phase II study of Dovitinib in recurrent glioblastoma. 
  • Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma. 
  • Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma. 
  • Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia. 
  • Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors. 
  • Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy. 
  • Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B. 
  • Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group. 
  • Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. 
  • Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. 
  • Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen. 
  • Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib. 
  • Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102). 
  • Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304). 
  • Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancer. 
  • Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma. 
  • Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma. 
  • Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma. 
  • Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902. 
  • Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. 
  • Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. 
  • Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430. 
  • Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002. 
  • Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). 
  • Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy. 
  • Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy. 
  • Phase II trial of weekly paclitaxel and gemcitabine for previously untreated, stage IIIB-IV nonsmall cell lung cancer. 
  • Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. 
  • Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance). 
  • Phase III randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma. 
  • Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer. 
  • Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. 
  • Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. 
  • Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial. 
  • Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. 
  • Physical and psychological health in rare cancer survivors. 
  • Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. 
  • Physical performance and subsequent disability and survival in older adults with malignancy: results from the health, aging and body composition study. 
  • Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. 
  • Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. 
  • Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance). 
  • Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure. 
  • Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. 
  • Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion. 
  • Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder. 
  • Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. 
  • Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer. 
  • Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. 
  • Polymorphisms of nucleotide excision repair genes predict melanoma survival. 
  • Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. 
  • Pompe disease in infants: improving the prognosis by newborn screening and early treatment. 
  • Pooled analysis of adverse event collection from 4 acute coronary syndrome trials. 
  • Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α. 
  • Positive margins: is adjunctive radiation therapy indicated? 
  • Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases. 
  • Positive therapeutic interaction between thiopurines and alkylating drugs in human glioma xenografts. 
  • Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer. 
  • Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings. 
  • Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI. 
  • Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR. 
  • Post-Traumatic Stress Disorder and Heart Failure in Men Within the Veteran Affairs Health System. 
  • Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B. 
  • Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study. 
  • Postimplantation ventricular ectopic burden and clinical outcomes in cardiac resynchronization therapy-defibrillator patients: a MADIT-CRT substudy. 
  • Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. 
  • Postoperative atrial fibrillation: Sex-specific characteristics and effect on survival. 
  • Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. 
  • Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. The Pediatric Oncology Group. 
  • Postoperative cognitive dysfunction and mortality following lung transplantation. 
  • Postoperative morbidity and mortality following total knee arthroplasty with computer navigation. 
  • Postoperative radiation therapy for high-risk colon carcinoma. 
  • Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule. 
  • Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria. 
  • Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. 
  • Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. 
  • Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. 
  • Potential of CT-scan based tumor volume as a response indicator in chemotherapy of advanced epithelial ovarian cancer. 
  • Potentially functional genetic variants of VAV2 and PSMA4 in the immune-activation pathway and non-small cell lung cancer survival. 
  • Power and sample size calculations for SNP association studies with censored time-to-event outcomes. 
  • Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial. 
  • Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. 
  • Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patients. 
  • Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial. 
  • Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival. 
  • Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. 
  • Predicting 6- and 12-Month Risk of Mortality in Patients With Platinum-Resistant Advanced-Stage Ovarian Cancer: Prognostic Model to Guide Palliative Care Referrals. 
  • Predicting non-organ-confined prostate cancer in men diagnosed after 2000. 
  • Predicting risk of cardiac events among ST-segment elevation myocardial infarction patients with conservatively managed non-infarct-related artery coronary artery disease: An analysis of the Duke Databank for Cardiovascular Disease. 
  • Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database. 
  • Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. 
  • Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. 
  • Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. 
  • Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. 
  • Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218. 
  • Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. 
  • Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis. 
  • Predictive indices of morbidity and mortality after liver resection. 
  • Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial. 
  • Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. 
  • Predictors and outcomes of heart failure with mid-range ejection fraction. 
  • Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. 
  • Predictors of Major Morbidity or Mortality After Resection for Esophageal Cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database Risk Adjustment Model. 
  • Predictors of Stroke, Myocardial Infarction or Death within 30 Days of Carotid Artery Stenting: Results from the International Carotid Stenting Study. 
  • Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. 
  • Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models. 
  • Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials. 
  • Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). 
  • Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy. 
  • Predictors of nosocomial bloodstream infections in older adults. 
  • Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response. 
  • Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry. 
  • Predictors of outcome of reperfusion therapy. 
  • Predictors of outcome of tricuspid valve replacement in carcinoid heart disease. 
  • Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs). 
  • Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study. 
  • Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. 
  • Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy. 
  • Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure. 
  • Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. 
  • Preliminary experience with split liver transplantation. 
  • Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation. 
  • Preoperative Evaluation and Indications for Pulmonary Metastasectomy. 
  • Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging. 
  • Preoperative anxiety as a predictor of mortality and major morbidity in patients aged >70 years undergoing cardiac surgery. 
  • Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer. 
  • Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. 
  • Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. 
  • Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. 
  • Preoperative irradiation for tethered rectal carcinoma. 
  • Preoperative mild-to-moderate coronary artery disease does not affect long-term outcomes of lung transplantation. 
  • Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. 
  • Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. 
  • Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. 
  • Preoperative radiotherapy for rectal cancer: benefits and controversies. 
  • Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts. 
  • Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure. 
  • Pretransplant antithymocyte globulin has increased efficacy in controlling donor-reactive memory T cells in mice. 
  • Pretransplant status and patient survival following liver transplantation. 
  • Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values and Tumor Size in Medically Inoperable Nonsmall Cell Lung Cancer Is Prognostic of Overall 2-Year Survival After Stereotactic Body Radiation Therapy. 
  • Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. 
  • Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. 
  • Prevalence and predictors of proteinuria in HIV-infected and uninfected pregnant women in Cameroon. 
  • Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study. 
  • Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality. 
  • Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation). 
  • Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. 
  • Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center. 
  • Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer. 
  • Primary brain and other central nervous system tumors in Appalachia: regional differences in incidence, mortality, and survival. 
  • Primary central nervous system lymphomas: a 30-year experience at a single institution. 
  • Primary central nervous system posttransplant lymphoproliferative disorders. 
  • Primary chest wall tumors. 
  • Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. 
  • Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis. 
  • Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. 
  • Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. 
  • Primary radiation therapy for early glottic cancer. 
  • Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma. 
  • Primary sarcomas of the pancreas: A review of 253 patients from the National Cancer Data Base. 
  • Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. 
  • Primary testicular lymphoma: the site matters. 
  • Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. 
  • Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification. 
  • Prognosis by coronary computed tomographic angiography: matched comparison with myocardial perfusion single-photon emission computed tomography. 
  • Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. 
  • Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial. 
  • Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure. 
  • Prognostic Value of Cardiac MR Imaging for Preoperative Assessment of Patients with Severe Functional Tricuspid Regurgitation. 
  • Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging. 
  • Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. 
  • Prognostic factors in infants and very young children with intracranial ependymomas. 
  • Prognostic factors in renal cancer. 
  • Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. 
  • Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. 
  • Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. 
  • Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. 
  • Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study. 
  • Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction. 
  • Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. 
  • Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. 
  • Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes. 
  • Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma. 
  • Prognostic indicators in hormone refractory prostate cancer. 
  • Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials. 
  • Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy. 
  • Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. 
  • Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. 
  • Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma. 
  • Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction. 
  • Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma. 
  • Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study. 
  • Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480. 
  • Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma. 
  • Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer. 
  • Prognostic significance of surgical margins after transoral laser microsurgery for early-stage glottic squamous cell carcinoma. 
  • Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma. 
  • Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients. 
  • Prognostic validation of the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index in inoperable non-small-cell lung cancer. 
  • Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma. 
  • Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors. 
  • Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis. 
  • Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients. 
  • Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis. 
  • Prognostic value of computed tomography texture features in non-small cell lung cancers treated with definitive concomitant chemoradiotherapy. 
  • Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions. 
  • Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686. 
  • Prognostic value of contrast-enhanced magnetic resonance imaging in brainstem gliomas. 
  • Prognostic value of estimated plasma volume in acute heart failure in three cohort studies. 
  • Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect. 
  • Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial). 
  • Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. 
  • Prognostic value of serum carcinoembryonic antigen levels in patients who undergo lung transplantation. 
  • Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST]). 
  • Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. 
  • Progress against childhood cancer: the Pediatric Oncology Group experience. 
  • Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors. 
  • Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN). 
  • Prolonged cardiopulmonary resuscitation and outcomes after out-of-hospital cardiac arrest. 
  • Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583. 
  • Proper staging techniques in testicular cancer patients. 
  • Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. 
  • Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators. 
  • Proportionate mortality among union members employed at three Texas refineries. 
  • Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. 
  • Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma. 
  • Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma. 
  • Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential. 
  • Prospective study of perceived stress in cardiac patients. 
  • Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis. 
  • Prostate cancer in young men: an important clinical entity. 
  • Prostate cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines. 
  • Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors. 
  • Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. 
  • Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer. 
  • Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. 
  • Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration. 
  • Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. 
  • Protective role of the apolipoprotein E2 allele in age-related disease traits and survival: evidence from the Long Life Family Study. 
  • Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75. 
  • Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials. 
  • Pulmonary embolism outcome: a prospective evaluation of CT pulmonary angiographic clot burden score and ECG score. 
  • Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. 
  • Pulmonary flow study predicts survival in pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. 
  • Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. 
  • Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. 
  • Pulmonary segmentectomy by thoracotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach. 
  • Pulse Pressure and Risk for Cardiovascular Events in Patients With Atherothrombosis: From the REACH Registry. 
  • Pulse pressure and long-term survival after coronary artery bypass graft surgery. 
  • Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. 
  • Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population. 
  • Putting class IIb recommendations to the test: the influence of unwitnessed and Non-VT/VF arrests on resource consumption and outcomes in therapeutic hypothermia and targeted temperature management. 
  • Puzzling role of genetic risk factors in human longevity: "risk alleles" as pro-longevity variants. 
  • Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice. 
  • Quality of life after coronary revascularization in the United States and Canada. 
  • Quality of life after intestinal transplantation. 
  • Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066. 
  • Quality of life and survival after II stage nonsmall cell carcinoma surgery: Video-assisted thoracic surgery versus thoracotomy lobectomy. 
  • Quality of life in patients with Barrett's esophagus undergoing surveillance. 
  • Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry. 
  • Quantifying the risk of incompatible kidney transplantation: a multicenter study. 
  • Quantifying the safety benefits of wedge resection: a society of thoracic surgery database propensity-matched analysis. 
  • Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. 
  • Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy. 
  • Race is an independent predictor of survival in patients with soft tissue sarcoma of the extremities. 
  • Race, resource use, and survival in seriously ill hospitalized adults. The SUPPORT Investigators. 
  • Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure. 
  • Racial Discrepancies in Overall Survival among Men Treated with 223Radium. 
  • Racial and gender disparities and the role of primary tumor type on inpatient outcomes following craniotomy for brain metastases. 
  • Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes. 
  • Racial differences in long-term survival among patients with coronary artery disease. 
  • Racial differences in survival post cerebral infarction among the elderly. 
  • Racial differences in the outcomes of patients with diastolic heart failure. 
  • Racial disparities among patients with lung cancer who were recommended operative therapy. 
  • Racial disparities in Medicaid patients after brain tumor surgery. 
  • Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis. 
  • Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer. 
  • Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? 
  • Racial, Ethnic, and Socioeconomic Disparities in Retinoblastoma Enucleation: A Population-Based Study, SEER 18 2000-2014. 
  • Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. 
  • Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer. 
  • Radiation therapy in the management of rectal cancer. 
  • Radical Minimally Invasive Surgery After Immuno-chemotherapy in Initially-unresectable Stage IIIB Non-small cell Lung Cancer. 
  • Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. 
  • Radical perineal prostatectomy: a model for evaluating local response of prostate therapy. 
  • Radical perineal prostatectomy: oncological outcome during a 20-year period. 
  • Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. 
  • Radical prostatectomy versus radiation therapy for clinically localized prostate carcinoma: the butcher and the baker selling their wares. 
  • Radical radiotherapy for T4 carcinoma of the skin of the head and neck: a multivariate analysis. 
  • Radioactive Iodine Treatment Is Associated with Improved Survival for Patients with Hürthle Cell Carcinoma. 
  • Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers. 
  • Radiofrequency ablation of liver tumors: influence of technique and tumor size. 
  • Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer. 
  • Radiologic findings of bronchogenic carcinoma with pulmonary metastases at presentation. 
  • Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease? 
  • Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. 
  • Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031. 
  • Radiotherapy management of patients diagnosed with glioma in Victoria (1998-2000): a retrospective cohort study. 
  • Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. 
  • Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. 
  • Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial. 
  • Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer. 
  • Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901. 
  • Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. 
  • Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. 
  • Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. 
  • Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group. 
  • Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. 
  • Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer. 
  • Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114). 
  • Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC. 
  • Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. 
  • Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732. 
  • Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480. 
  • Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. 
  • Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer. 
  • Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed. 
  • Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. 
  • Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. 
  • Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. 
  • Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. 
  • Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma. 
  • Rank tests for clustered survival data. 
  • Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). 
  • Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF. 
  • Rates of new neurological deficit associated with spine surgery based on 108,419 procedures: a report of the scoliosis research society morbidity and mortality committee. 
  • Ratings of positive and depressive emotion as predictors of mortality in coronary patients. 
  • Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial. 
  • Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial. 
  • Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. 
  • Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. 
  • Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial. 
  • Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty. 
  • Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. 
  • Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). 
  • Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure. 
  • Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. 
  • Re: Mortality and follow-up colonoscopy after colorectal cancer. 
  • Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes. 
  • Readmission rates and long-term hospital costs among survivors of an in-hospital cardiac arrest. 
  • Reassessing Recipient Mortality Under the New Heart Allocation System: An Updated UNOS Registry Analysis. 
  • Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction. 
  • Recent advances in the treatment of prostate cancer. 
  • Recent progress in metabolic signaling pathways regulating aging and life span. 
  • Recognition of early mortality in multiple myeloma by a prediction matrix. 
  • Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. 
  • Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808. 
  • Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care: A Scientific Statement From the American Heart Association. 
  • Recovery and survival from aging-associated diseases. 
  • Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes. 
  • Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria. 
  • Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection. 
  • Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria. 
  • Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis. 
  • Recurrent Glioblastoma Treated with Recombinant Poliovirus. 
  • Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries. 
  • Recurrent malignant melanoma: the identification of prognostic factors to predict survival. 
  • Red blood cell transfusion threshold and mortality in cardiac intensive care unit patients. 
  • Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts. 
  • Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease. 
  • Reduced oxygen concentration for the resuscitation of infants with congenital diaphragmatic hernia. 
  • Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002). 
  • Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901. 
  • Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002). 
  • Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. 
  • Reduction in Mortality after Umbilical Cord Blood Transplantation in Children Over a 20-Year Period (1995-2014). 
  • Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial. 
  • Reevaluating the prognostic significance of age in differentiated thyroid cancer. 
  • Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? 
  • Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma. 
  • Regional Adiposity and Risk of Heart Failure and Mortality: The Jackson Heart Study. 
  • Regional Variation in Out-of-Hospital Cardiac Arrest Survival in the United States. 
  • Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. 
  • Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations. 
  • Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators. 
  • Regional left ventricular function does not predict survival in ischaemic cardiomyopathy after cardiac surgery. 
  • Regional systems of care for ST-elevation myocardial infarction: do they save lives? 
  • Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial. 
  • Regional versus general anesthesia for carotid endarterectomy: the American College of Surgeons National Surgical Quality Improvement Program perspective. 
  • Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. 
  • Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty. 
  • Relation of Admission Blood Pressure to In-hospital and 90-Day Outcomes in Patients Presenting With Transient Ischemic Attack. 
  • Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials). 
  • Relation of Early Repolarization (J Point Elevation) to Mortality in Blacks (from the Jackson Heart Study). 
  • Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease. 
  • Relation of Postdischarge Care Fragmentation and Outcomes in Transcatheter Aortic Valve Implantation from the STS/ACC TVT Registry. 
  • Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial). 
  • Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry). 
  • Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]). 
  • Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. 
  • Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. 
  • Relation of ventricular premature complexes during recovery from a myocardial perfusion exercise stress test to myocardial ischemia. 
  • Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial. 
  • Relationship Between Hospital Characteristics and Early Adoption of Angiotensin-Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure. 
  • Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials. 
  • Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. 
  • Relationship between community hospital versus pre-hospital location of randomisation and clinical outcomes in ST-elevation myocardial infarction patients: insights from the Stream study. 
  • Relationship between disease-free interval and survival in patients with recurrent melanoma. 
  • Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI. 
  • Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. 
  • Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials. 
  • Relationship between tumor response at therapy completion and prognosis in patients with Group III rhabdomyosarcoma: A report from the Children's Oncology Group. 
  • Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study. 
  • Relationship of body mass index to subsequent mortality among seriously ill hospitalized patients. SUPPORT Investigators. The Study to Understand Prognoses and Preferences for Outcome and Risks of Treatments. 
  • Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. 
  • Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT). 
  • Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation. 
  • Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer. 
  • Relative impact of surgeon and center volume on early mortality after the Norwood operation. 
  • Relative prognostic value of baseline Q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. 
  • Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studies. 
  • Relatively short diagnostic delays (<8 hours) produce morbidity and mortality in blunt small bowel injury: an analysis of time to operative intervention in 198 patients from a multicenter experience. 
  • Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer. 
  • Renal Dysfunction and In-Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy. 
  • Renal Outcomes in Patients Bridged to Heart Transplant With a Left Ventricular Assist Device. 
  • Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy. 
  • Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes. 
  • Renal function trajectories and clinical outcomes in acute heart failure. 
  • Renal medullary carcinoma: A national analysis of 159 patients. 
  • Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001. 
  • Resected irradiated rectal cancers: Are twelve lymph nodes really necessary in the era of neoadjuvant therapy? 
  • Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. 
  • Resection of adrenocortical carcinoma liver metastasis: is it justified? 
  • Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. 
  • Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. 
  • Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. 
  • Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma. 
  • Resection of the irradiated esophagus: the impact of lymph node yield on survival. 
  • Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone. 
  • Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma. 
  • Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. 
  • Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904. 
  • Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study. 
  • Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity as a risk factor in coronary artery disease. 
  • Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer. 
  • Results of radiation therapy in gastric cancer. 
  • Results of recent large myocardial infarction trials, adjunctive therapies, and acute myocardial infarction: improving outcomes. 
  • Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy. 
  • Results of the Chronic Heart Failure Intervention to Improve MEdication Adherence study: A randomized intervention in high-risk patients. 
  • Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. 
  • Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. 
  • Results of thoracic endovascular aortic repair 6 years after United States Food and Drug Administration approval. 
  • Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. 
  • Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis. 
  • Retinal arteriolar narrowing and left ventricular remodeling: the multi-ethnic study of atherosclerosis. 
  • Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant. 
  • Retransplantation of the liver--a seven-year experience. 
  • Retreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancer. 
  • Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. 
  • Revascularization improves survival in ischemic cardiomyopathy regardless of electrocardiographic criteria for prior small-to-medium myocardial infarcts. 
  • Revascularization of the femoral head in osteonecrosis. 
  • Right ventricular echocardiographic indices predict poor outcomes in infants with persistent pulmonary hypertension of the newborn. 
  • Right ventricular gene therapy with a beta-adrenergic receptor kinase inhibitor improves survival after pulmonary artery banding. 
  • Risk Analysis and Outcomes of Postoperative Renal Failure After Aortic Valve Surgery in the United States. 
  • Risk Prediction Model for Major Adverse Outcome in Proximal Thoracic Aortic Surgery. 
  • Risk assessment of patients having congenital heart disease using electrophysiologic testing: finally, opening the right door...or, an impossible chore? 
  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation. 
  • Risk factors for cerebrovascular events following fontan palliation in patients with a functional single ventricle. 
  • Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. 
  • Risk factors for morbidity after lobectomy for lung cancer in elderly patients. 
  • Risk factors for mortality in lung transplant recipients aged ≥65 years: A retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients. 
  • Risk factors for oligodendroglial tumors: a pooled international study. 
  • Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X. 
  • Risk of atrioesophageal fistula formation with contact force-sensing catheters. 
  • Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry. 
  • Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry. 
  • Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. 
  • Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement. 
  • Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. 
  • Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. 
  • Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes. 
  • Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival. 
  • Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era. 
  • Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution. 
  • Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. 
  • Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children. 
  • Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation. 
  • Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin. 
  • Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review. 
  • Role of surgical intervention in the management of intestinal metastases from malignant melanoma. 
  • Role of target vessel size and body surface area on outcomes after percutaneous coronary interventions in women. 
  • Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study. 
  • Root replacement surgery versus more conservative management during type A acute aortic dissection repair. 
  • Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer. 
  • Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study. 
  • S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach. 
  • SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death. 
  • SET alpha and SET beta mRNA isoforms in chronic lymphocytic leukaemia. 
  • ST-segment resolution and outcome in myocardial infarction. 
  • STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment. 
  • SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study). 
  • Safety and Efficacy of Radiation Therapy in Advanced Melanoma Patients Treated With Ipilimumab. 
  • Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009). 
  • Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort study. 
  • Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group. 
  • Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study. 
  • Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double-blind, placebo-controlled trial. 
  • Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. 
  • Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer. 
  • Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population. 
  • Salvage Focal Cryotherapy Offers Similar Short-term Oncologic Control and Improved Urinary Function Compared With Salvage Whole Gland Cryotherapy for Radiation-resistant or Recurrent Prostate Cancer. 
  • Sarcomas arising in Paget disease of bone: a clinicopathologic analysis of 70 cases. 
  • Sarcopenia as a prognostic factor among patients with stage III melanoma. 
  • Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B. 
  • Scoliosis research society morbidity and mortality of adult scoliosis surgery. 
  • Seasonal and circadian variations of acute myocardial infarction: Findings from the Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program. 
  • Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials. 
  • Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG). 
  • Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes. 
  • Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study. 
  • Selection factors for local excision or abdominoperineal resection of early stage rectal cancer. 
  • Selection of Postacute Stroke Rehabilitation Facilities: A Survey of Discharge Planners From the Northeast Cerebrovascular Consortium (NECC) Region. 
  • Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators. 
  • Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences. 
  • Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies. 
  • Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma. 
  • Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study. 
  • Sepsis may not be a risk factor for mortality in patients with acute kidney injury treated with continuous renal replacement therapy. 
  • Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors. 
  • Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study. 
  • Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. 
  • Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism. 
  • Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. 
  • Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response. 
  • Serum albumin is independently associated with higher mortality in adult sickle cell patients: Results of three independent cohorts. 
  • Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. 
  • Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. 
  • Sex Differences in Mortality Based on United Network for Organ Sharing Status While Awaiting Heart Transplantation. 
  • Sex and Racial Disparities in Cardiac Rehabilitation Referral at Hospital Discharge and Gaps in Long-Term Mortality. 
  • Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study. 
  • Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. 
  • Sex differences in long-term outcomes of patients across the spectrum of coronary artery disease. 
  • Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014. 
  • Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years. 
  • Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). 
  • Sex-specific gene and pathway modeling of inherited glioma risk. 
  • Shock Index Predicts Patient-Related Clinical Outcomes in Stroke. 
  • Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate permanent brachytherapy in early-stage prostate cancer: a matched subset analysis. 
  • Short-term complications associated with surgery for high-grade spondylolisthesis in adults and pediatric patients: a report from the scoliosis research society morbidity and mortality database. 
  • Short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous coronary intervention: Implications for patients requiring early coronary artery bypass surgery. 
  • Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians?: Insights From the STS/ACC TVT Registry. 
  • Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial. 
  • Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. 
  • Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. 
  • Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. 
  • Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity. 
  • Simultaneous pancreas-kidney transplantation at University of Wisconsin-Madison Hospital. 
  • Simultaneous pancreas-kidney transplantation at the University of Wisconsin. 
  • Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. 
  • Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). 
  • Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. 
  • Single-center experience of transplantation for polycystic liver disease. 
  • Single-photon emission computed tomography myocardial perfusion imaging-assessed stress perfusion defect severity is associated with mortality independent of ethnicity in an Asian population. 
  • Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit? 
  • Size of Anterior Wall Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention in United States Versus Europe/Australia Versus India (from the CRISP-AMI Randomized Controlled Trial). 
  • Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study. 
  • Skin melanoma. Cured fraction and survival time as functions of thickness, site, histologic type, age, and sex. 
  • Sleep Breathing Disorders in Heart Failure. 
  • Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival. 
  • Small-cell lung cancer: prognostic factors and changing treatment over 15 years. 
  • Smoking Status and Survival Among a National Cohort of Lung and Colorectal Cancer Patients. 
  • Smoking and Physical Activity Explain the Increased Mortality Risk Following Marital Separation and Divorce: Evidence From the English Longitudinal Study of Ageing. 
  • Social bonds of female baboons enhance infant survival. 
  • Social network diversity and risks of ischemic heart disease and total mortality: findings from the Copenhagen City Heart Study. 
  • Sociodemographic and clinical predictors of mortality in geriatric depression. 
  • Socioeconomic Status, Not Race, Is Associated With Reduced Survival in Esophagectomy Patients. 
  • Socioeconomic status and outcome following acute myocardial infarction in elderly patients. 
  • Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study. 
  • Solid organ transplantation in primary mitochondrial disease: Proceed with caution. 
  • Solitary pancreas transplantation. Experience with 62 consecutive cases. 
  • Sorafenib for Advanced and Refractory Desmoid Tumors. 
  • Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy. 
  • Sphincter preservation in rectal cancer. Local excision followed by postoperative radiation therapy. 
  • Sphincter-sparing surgery in patients with low-lying rectal cancer: techniques, oncologic outcomes, and functional results. 
  • Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation. 
  • Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial. 
  • Squamous cell carcinoma of the temporal bone: a radiographic-pathologic correlation. 
  • Stacked proximal aortic cuffs: an "off-the-shelf" solution for treating focal thoracic aortic pathology. 
  • Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. 
  • Stage IA non-small cell lung cancer: a small proportion of cases in the general population. 
  • Staging of Bilateral Lung Transplantation for High-Risk Patients With Interstitial Lung Disease: One Lung at a Time. 
  • Staging of pancreatic cancer before and after neoadjuvant chemoradiation. 
  • Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study. 
  • Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease. 
  • Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database. 
  • Statistical considerations for the design and analysis of Phase III clinical trials in prostate cancer. 
  • Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer. 
  • Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting? 
  • Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium. 
  • Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer. 
  • Stress resistance declines with age: analysis of data from a survival experiment with Drosophila melanogaster. 
  • Strict glycemic targets need not be so strict: a more permissive glycemic range for critically ill children. 
  • Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor Study. 
  • Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. 
  • Stroke of Known Cause and Underlying Atrial Fibrillation (STROKE-AF) randomized trial: Design and rationale. 
  • Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. 
  • Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis. 
  • Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. 
  • Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. 
  • Subcutaneously administered recombinant human interleukin-2 and interferon alfa-2a for advanced breast cancer: a phase II study of the Cancer and Leukemia Group B (CALGB 9041). 
  • Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States. 
  • Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial). 
  • Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF. 
  • Suicide in HF Patients: A Call for Recognition. 
  • Suicide risk among cancer survivors: Head and neck versus other cancers. 
  • Sunitinib efficacy against advanced renal cell carcinoma. 
  • Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid. 
  • Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors. 
  • Surgery Is Associated With Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis. 
  • Surgery for colorectal cancer in elderly patients: a systematic review. Colorectal Cancer Collaborative Group. 
  • Surgery for hip fracture yields societal benefits that exceed the direct medical costs. 
  • Surgery of the primary tumor does not improve survival in stage IV breast cancer. 
  • Surgical Management of Non-small Cell Lung Cancer with Solitary Hematogenous Metastases. 
  • Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone. 
  • Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor. 
  • Surgical considerations in lung transplantation: transplant operation and early postoperative management. 
  • Surgical management of Merkel cell carcinoma. 
  • Surgical management of advanced gastrointestinal stromal tumors: an international multi-institutional analysis of 158 patients. 
  • Surgical management of bilateral synchronous kidney tumors: functional and oncological outcomes. 
  • Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing? 
  • Surgical resection for small hepatocellular carcinoma. 
  • Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). 
  • Surgical staging for endometrial cancer in the elderly - is there a role for lymphadenectomy? 
  • Surgical therapy of cutaneous melanoma. 
  • Surgical treatment of malignant esophageal tumors in PUMC Hospital. 
  • Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data. 
  • Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. 
  • Surveillance issues in inflammatory bowel disease: ulcerative colitis. 
  • Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. 
  • Survival After Exercise-Related Sudden Cardiac Arrest in Young Athletes: Can We Do Better? 
  • Survival After MI in a Community Cohort Study: Contribution of Comorbidities in NSTEMI. 
  • Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer. 
  • Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation. 
  • Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States. 
  • Survival Outcomes in Sinonasal Poorly Differentiated Squamous Cell Carcinoma. 
  • Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis. 
  • Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era. 
  • Survival after age 80. 
  • Survival after bronchiolitis obliterans syndrome. 
  • Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation. 
  • Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. 
  • Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis. 
  • Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. 
  • Survival after the age of 80 in the United States, Sweden, France, England, and Japan. 
  • Survival after traumatic brain injury improves with deployment of neurosurgeons: a comparison of US and UK military treatment facilities during the Iraq and Afghanistan conflicts. 
  • Survival analysis of presumptive prognostic markers among oligodendrogliomas. 
  • Survival and Neurodevelopmental Outcomes among Periviable Infants. 
  • Survival and polyethylene wear of porous-coated acetabular components in patients less than fifty years old: results at nine to fourteen years. 
  • Survival at 5 years of a cohort of newborn infants with myelomeningocele. 
  • Survival differences among native-born and foreign-born older adults in the United States. 
  • Survival following minimally invasive radical hysterectomy for patients with cervical carcinoma and tumor size ≤2 cm. 
  • Survival in critical illness is associated with early activation of mitochondrial biogenesis. 
  • Survival in renal vascular disease. 
  • Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. 
  • Survival of patients removed from the heart transplant waiting list. 
  • Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. 
  • Survival of patients undergoing rescue percutaneous coronary intervention: development and validation of a predictive tool. 
  • Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. 
  • Survival of related individuals: an extension of some fundamental results of heterogeneity analysis. 
  • Survival outcomes in sinonasal carcinoma with neuroendocrine differentiation: A NCDB analysis. 
  • Survival prognosis and surgical management of ischemic mitral regurgitation. 
  • Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis. 
  • Survival risk assessment for primary blast exposures to the head. 
  • Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients. 
  • Survivors of childhood cancer have increased risk of gastrointestinal complications later in life. 
  • Survivors of childhood cancer: an Australian audit of vaccination status after treatment. 
  • Survivorship in adults with malignant brain and other central nervous system tumor from 2000-2014. 
  • Sustainability and long-term effectiveness of the WHO surgical safety checklist combined with pulse oximetry in a resource-limited setting: two-year update from Moldova. 
  • Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer. 
  • Synchronous resection of esophageal cancer and other organ malignancies: A systematic review. 
  • Synchronous resection of primary and liver metastases for neuroendocrine tumors. 
  • Synergistic effect of influenza a virus on endotoxin-induced mortality in rat pups: a potential model for sudden infant death syndrome. 
  • Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? 
  • Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. 
  • Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. 
  • Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes. 
  • Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? 
  • T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma. 
  • T-wave alternans and ST depression assessment identifies low risk individuals with ischemic cardiomyopathy in the absence of left ventricular hypertrophy. 
  • T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction? 
  • TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. 
  • TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx. 
  • Tailoring your heart failure project for success in rural areas. 
  • Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. 
  • Targeted expression of calmodulin increases ventricular cardiomyocyte proliferation and deoxyribonucleic acid synthesis during mouse development. 
  • Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. 
  • Targeted investment improves access to hospice and palliative care. 
  • Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease. 
  • Targeting anemia in patients with lung cancer. 
  • Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome. 
  • Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. 
  • Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. 
  • Technological advances in extracorporeal membrane oxygenation for respiratory failure. 
  • Temozolomide in pediatric low-grade glioma. 
  • Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma. 
  • Temperature profile and outcomes of neonates undergoing whole body hypothermia for neonatal hypoxic-ischemic encephalopathy. 
  • Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial). 
  • Temporal differences in out-of-hospital cardiac arrest incidence and survival. 
  • Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study). 
  • Temporal trends in target vessel revascularization in clinical practice: long-term outcomes following coronary stenting from the Duke Database for Cardiovascular Disease. 
  • Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE). 
  • Ten dimensions of health and their relationships with overall self-reported health and survival in a predominately religiously active elderly population: the cache county memory study. 
  • Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure). 
  • Ten-year evolution of retinopathy lesions in an older nondiabetic population. 
  • Ten-year experience with extended criteria cardiac transplantation. 
  • Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission. 
  • Ten-year survival and clinical results of constrained components in primary total knee arthroplasty. 
  • Testicular cancer survivorship: research strategies and recommendations. 
  • Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing program. 
  • Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. 
  • Thalidomide as salvage therapy for chronic graft-versus-host disease. 
  • The AOSpine North America Geriatric Odontoid Fracture Mortality Study: a retrospective review of mortality outcomes for operative versus nonoperative treatment of 322 patients with long-term follow-up. 
  • The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer. 
  • The Association of Hydrocortisone Dosage on Mortality in Infants Born Extremely Premature. 
  • The Bird's Nest Filter. An alternative to long-term oral anticoagulation in patients with advanced malignancies. 
  • The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction. 
  • The Cholesterol, Hypertension, And Glucose Education (CHANGE) study: results from a randomized controlled trial in African Americans with diabetes. 
  • The Cost to Medicare of Bladder Cancer Care. 
  • The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. 
  • The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. 
  • The Effect of Timing of Adjuvant Therapy on Survival After Esophagectomy. 
  • The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer. 
  • The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up. 
  • The Geneva prognostic score and mortality in patients diagnosed with pulmonary embolism by CT pulmonary angiogram. 
  • The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. 
  • The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. 
  • The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. 
  • The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. 
  • The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma. 
  • The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer. 
  • The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer. 
  • The Incidence and Outcomes of Surgical Pulmonary Embolectomy in North America. 
  • The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implications. 
  • The J wave patterns and risk of sudden cardiac death in patients with coronary artery disease. 
  • The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison. 
  • The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. 
  • The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19. 
  • The Obesity and Heart Failure Epidemics Among African Americans: Insights From the Jackson Heart Study. 
  • The Optimal Timing of Stage 2 Palliation for Hypoplastic Left Heart Syndrome: An Analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Data Set. 
  • The PLATO trial reveals further opportunities to improve outcomes in patients with acute coronary syndrome. Editorial on Serebruany. "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5). 
  • The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer. 
  • The Prognosis of Hepatocellular Carcinoma Treated with Sorafenib in Combination with TACE. 
  • The Racial Paradox in Multiarterial Conduit Utilization for Coronary Artery Bypass Grafting. 
  • The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients. 
  • The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma. 
  • The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients. 
  • The Ross procedure: shorter hospital stay, decreased morbidity, and cost effective. 
  • The Society of Thoracic Surgeons 2021 Adult Cardiac Surgery Risk Models for Multiple Valve Operations. 
  • The Society of Thoracic Surgeons Composite Score Rating for Pulmonary Resection for Lung Cancer. 
  • The Society of Thoracic Surgeons Isolated Aortic Valve Replacement (AVR) Composite Score: a report of the STS Quality Measurement Task Force. 
  • The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes. 
  • The Society of Thoracic Surgeons Mitral Valve Repair/Replacement Plus Coronary Artery Bypass Grafting Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force. 
  • The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery. 
  • The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study. 
  • The U-shaped response of initial mortality in Caenorhabditis elegans to mild heat shock: does it explain recent trends in human mortality? 
  • The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer. 
  • The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer. 
  • The accuracy of predicting survival in individual patients with cancer. 
  • The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer. 
  • The association between body mass index and coronary artery disease severity: a comparison of black and white patients. 
  • The association of chronic lung disease with early mortality and respiratory adverse events after aortic valve replacement. 
  • The association of donor age and survival is independent of ischemic time following deceased donor lung transplantation. 
  • The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States. 
  • The clinical significance of tenascin-C splice variant expression in chondrosarcoma. 
  • The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. 
  • The cumulative effect of unemployment on risks for acute myocardial infarction. 
  • The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. 
  • The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropenia. 
  • The effect of darbepoetin alfa on growth, oxygenation and radioresponsiveness of a breast adenocarcinoma. 
  • The effect of do-not-resuscitate status on postoperative mortality in the elderly following emergency surgery. 
  • The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer. 
  • The effect of filgrastim or pegfilgrastim on survival outcomes of patients with cancer receiving myelosuppressive chemotherapy. 
  • The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance). 
  • The effect of prior pneumonectomy or lobectomy on subsequent lung transplantation. 
  • The effect of the setting of a positive surgical margin in soft tissue sarcoma. 
  • The effectiveness of ovarian cancer screening. A decision analysis model. 
  • The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. 
  • The effects of New York's bypass surgery provider profiling on access to care and patient outcomes in the elderly. 
  • The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. 
  • The effects of health changes on projections of health service needs for the elderly population of the United States. 
  • The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. 
  • The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review. 
  • The efficacy of anti-PD-1 agents in acral and mucosal melanoma. 
  • The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades. 
  • The evolution of care improves outcome in blunt thoracic aortic injury: A Western Trauma Association multicenter study. 
  • The evolving role of radiotherapy in treatment of oligometastatic NSCLC. 
  • The health burden of diabetes for the elderly in four communities. 
  • The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. 
  • The hepatitis C crisis in the African American Community: findings and recommendations. 
  • The heritability of mortality due to heart diseases: a correlated frailty model applied to Danish twins. 
  • The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation. 
  • The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma. 
  • The impact of clinical vs administrative claims coding on hospital risk-adjusted outcomes. 
  • The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience. 
  • The impact of nodal isolated tumor cells on survival of breast cancer patients. 
  • The impact of post-transplant diabetes mellitus on liver transplant outcomes. 
  • The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B Trials. 
  • The impact of race on survival after heart transplantation: an analysis of more than 20,000 patients. 
  • The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. 
  • The importance of patient-specific preoperative factors: an analysis of the society of thoracic surgeons congenital heart surgery database. 
  • The incidence and significance of bacteremia in out of hospital cardiac arrest. 
  • The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. 
  • The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. 
  • The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: do race and gender matter? 
  • The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST. 
  • The knowledge and perceptions of medical personnel relating to outcome after cardiac arrest. 
  • The long-term clinical course of patients with cutaneous melanoma. 
  • The long-term dynamics of mortality benefits from improved water and sanitation in less developed countries. 
  • The management of intraductal papillary mucinous neoplasms of the pancreas. 
  • The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. 
  • The natural history of hepatitis C viral infection. 
  • The natural history of single-vessel chronic coronary occlusion: a 25-year experience. 
  • The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. 
  • The number of lymph nodes dissected in breast cancer patients influences the accuracy of prognosis. 
  • The obesity paradox, extreme obesity, and long-term outcomes in older adults with ST-segment elevation myocardial infarction: results from the NCDR. 
  • The oligometastatic state - separating truth from wishful thinking. 
  • The oncogenic gene fusion TMPRSS2: ERG is not a diagnostic or prognostic marker for ovarian cancer. 
  • The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortality. 
  • The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysis. 
  • The prognostic role of body mass index on mortality amongst the middle-aged and elderly: a competing risk analysis. 
  • The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. 
  • The prognostic value of diastolic and systolic mechanical left ventricular dyssynchrony among patients with coronary artery disease and heart failure. 
  • The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine. 
  • The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. 
  • The rationale and design of the AASK cohort study. 
  • The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients? 
  • The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial. 
  • The relevance of stage A malignancy in prostatic cancer. 
  • The rising tide of asthma. Trends in the epidemiology of morbidity and mortality from asthma. 
  • The risk of risk-adjustment measures for perioperative spine infection after spinal surgery. 
  • The risk of subsequent fractures in community-dwelling men and male veterans with hip fracture. 
  • The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. 
  • The role of bystanders, first responders, and emergency medical service providers in timely defibrillation and related outcomes after out-of-hospital cardiac arrest: Results from a statewide registry. 
  • The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma. 
  • The role of neoadjuvant chemotherapy, lymph node dissection, and treatment delay in patients with muscle-invasive bladder cancer undergoing partial cystectomy. 
  • The role of optimal debulking in advanced stage serous carcinoma of the uterus. 
  • The role of radiation therapy in resected T2 N0 esophageal cancer: a population-based analysis. 
  • The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature. 
  • The role of targeted therapy in the treatment of colorectal cancer. 
  • The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. 
  • The role of whole brain radiation therapy in the management of melanoma brain metastases. 
  • The safety and versatility of video-thoracoscopy: a prospective analysis of 895 consecutive cases. 
  • The side of the primary tumor affects overall survival in colon adenocarcinoma: an analysis of the national cancer database. 
  • The significance of pre-operative coronary interventions on outcome after pancreas transplantation. 
  • The society of thoracic surgeons 30-day predicted risk of mortality score also predicts long-term survival. 
  • The structure of critical care transfer networks. 
  • The treatment of colorectal carcinoma: standard chemotherapy and beyond. 
  • The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. 
  • The use of UW solution in clinical transplantation. A 4-year experience. 
  • The use of electrocautery as the primary ablation modality for malignant and benign airway obstruction. 
  • The use of radiation therapy in localized high-grade soft tissue sarcoma and potential impact on survival. 
  • The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates. 
  • The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma. 
  • The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. 
  • Therapeutic Hypothermia for Patients with Out-of-Hospital Cardiac Arrest in North Carolina. 
  • Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxyl) ethylamino-12,13-dihydro-13-(beta-D-glucopyranosyl) -5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6H)-dione]] against pediatric and adult central nervous system tumor xenografts. 
  • Therapeutic effects of diethylcarbamazine and 3'-azido-3'-deoxythymidine on feline leukemia virus lymphoma formation. 
  • Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators. 
  • Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features. 
  • Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trial. 
  • There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. 
  • Thin malignant melanomas of the head and neck. 
  • Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032. 
  • Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery. 
  • Thoracic endovascular aortic repair for chronic DeBakey IIIb aortic dissection. 
  • Thoracic metastasectomy for adoptive immunotherapy of melanoma: a single-institution experience. 
  • Thoracic organ transplantation at Papworth Hospital. 
  • Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy. 
  • Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. 
  • Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. 
  • Thoratec VAD system as a bridge to heart transplantation. 
  • Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. 
  • Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses. 
  • Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients. 
  • Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. 
  • Time Trends and Educational Inequalities in Out-of-Hospital Coronary Deaths in Norway 1995-2009: A Cardiovascular Disease in Norway (CVDNOR) Project. 
  • Time to reperfusion in acute myocardial infarction. It is time to reduce it! 
  • Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial. 
  • Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial. 
  • Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making. 
  • Time-dependent risk of Fidelis lead failure. 
  • Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711). 
  • Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. 
  • Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. 
  • Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes. 
  • Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers. 
  • Timing of commencement of maintenance dialysis and mortality in young and older adults in Singapore. 
  • Tobacco smoking and death from prostate cancer in US veterans. 
  • Toluene abuse embryopathy: longitudinal neurodevelopmental effects of prenatal exposure to toluene in rats. 
  • Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia. 
  • Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). 
  • Toward more optimal use of primary prevention implantable cardioverter-defibrillators: how do we get there? 
  • Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis. 
  • Trajectories of Changes in Renal Function in Patients with Acute Heart Failure. 
  • Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). 
  • Trajectory of overall health from self-report and factors contributing to health declines among cancer survivors. 
  • Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States. 
  • Transcatheter Aortic Valve Replacement After Prior Mitral Valve Surgery: Results From the Transcatheter Valve Therapy Registry. 
  • Transcatheter Aortic Valve Replacement Versus Aortic Valve Bypass: A Comparison of Outcomes and Economics. 
  • Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral Regurgitation. 
  • Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry. 
  • Transcatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched Comparison. 
  • Transcatheter aortic valve replacement for patients with severe bicuspid aortic stenosis. 
  • Transcatheter aortic-valve replacement with a self-expanding prosthesis. 
  • Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting. 
  • Transfusion of blood components containing ABO-incompatible plasma does not lead to higher mortality in civilian trauma patients. 
  • Transgenic expression of pancreatic secretory trypsin inhibitor-1 rescues SPINK3-deficient mice and restores a normal pancreatic phenotype. 
  • Transition to adult care in sickle cell disease: A longitudinal study of clinical characteristics and disease severity. 
  • Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure. 
  • Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist. 
  • Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. 
  • Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice. 
  • Transplantation outcomes for severe combined immunodeficiency, 2000-2009. 
  • Transradial Versus Transfemoral Access in Patients Undergoing Rescue Percutaneous Coronary Intervention After Fibrinolytic Therapy. 
  • Trastuzumab emtansine for HER2-positive advanced breast cancer. 
  • Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial. 
  • Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry. 
  • Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States. 
  • Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®). 
  • Treatment at Integrated Centers Might Bridge the Academic-Community Survival Gap in Patients With Metastatic Non-Small Cell Carcinoma of the Lung. 
  • Treatment choices in chronic myelogenous leukemia. 
  • Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs. 
  • Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection. 
  • Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab. 
  • Treatment of cervical necrotizing fasciitis with hyperbaric oxygen therapy. 
  • Treatment of endometrial stromal tumors. 
  • Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease. 
  • Treatment of head and neck cancer. 
  • Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. 
  • Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. 
  • Treatment of osseous metastases in patients with renal cell carcinoma. 
  • Treatment of patients with pineoblastoma with high dose cyclophosphamide. 
  • Treatment outcome of aneurysmal subarachnoid hemorrhage in patients aged 70 years and older. 
  • Treatment outcomes of necrotizing enterocolitis for preterm infants. 
  • Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States. 
  • Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria. 
  • Treatment selection for coronary artery disease: The collision of a belief system with evidence. 
  • Treatment selection for coronary artery disease: the collision of a belief system with evidence. 
  • Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States. 
  • Trends and Outcomes of Alternative-Access Transcatheter Aortic Valve Replacement. 
  • Trends and outcomes of cardiac transplantation from donors dying of drug intoxication. 
  • Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study. 
  • Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of The Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012. 
  • Trends in anemia management in US hemodialysis patients 2004-2010. 
  • Trends in management of ureteral urothelial carcinoma and effects on survival: a hospital-based registry study. 
  • Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001. 
  • Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. 
  • Trends in survival and recovery from stroke: evidence from the National Long-Term Care Survey/Medicare data. 
  • Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia. 
  • Tricuspid Valve Regurgitation Immediately After Heart Transplant and Long-Term Outcomes. 
  • Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation. 
  • Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. 
  • Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better? 
  • Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. 
  • Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy. 
  • Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome. 
  • Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients. 
  • Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class. 
  • Tunneled internal jugular hemodialysis catheters: impact of laterality and tip position on catheter dysfunction and infection rates. 
  • Tunneled peritoneal drainage catheter placement for refractory ascites: single-center experience in 188 patients. 
  • Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study. 
  • Two-year outcome after angiographically documented myocardial reperfusion for acute coronary occlusion. Thrombolysis and Angioplasty Study Group. 
  • Two-year outcomes after transcatheter or surgical aortic-valve replacement. 
  • Underutilization of surgical resection in patients with pancreatic acinar cell carcinoma. 
  • Unexpected observations on tumor size and survival in stage IA non-small cell lung cancer. 
  • Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. 
  • Unique features of breast cancer in Taiwan. 
  • Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. 
  • Unknown primary tumors metastatic to liver. 
  • Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. 
  • Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. 
  • Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. 
  • Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. 
  • Update in non-small cell lung cancer. 
  • Update: vinorelbine (navelbine) in non-small cell lung cancer. 
  • Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. 
  • Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer. 
  • Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma. 
  • Updating an Empirically Based Tool for Analyzing Congenital Heart Surgery Mortality. 
  • Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients. 
  • Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. 
  • Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure. 
  • Urological complications and enteric conversion after pancreas transplantation with bladder drainage. 
  • Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base. 
  • Use and outcomes of neoadjuvant chemotherapy for metastatic uterine cancer. 
  • Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma. 
  • Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease. 
  • Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes. 
  • Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. 
  • Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG). 
  • Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease. 
  • Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases. 
  • Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer. 
  • Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. 
  • Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants. 
  • Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis. 
  • Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study. 
  • Use of prophylactic antibiotics in women with previable prelabor rupture of membranes. 
  • Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial). 
  • Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). 
  • Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure. 
  • Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial). 
  • Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. 
  • Usefulness of spironolactone in a specialized heart failure clinic. 
  • Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma. 
  • Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. 
  • Using survival curve comparisons to inform patient decision making can a practice exercise improve understanding? 
  • Uteroglobin: a potential novel tumor suppressor and molecular therapeutic for prostate cancer. 
  • Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigation. 
  • Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation. 
  • Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma. 
  • Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma. 
  • Utilization and tailoring of interventional radiology procedures in small bowel transplants. 
  • Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation. 
  • Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes. 
  • Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers. 
  • Utilization of pediatric donors for pancreas transplantation. 
  • Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines. 
  • Uveal melanoma: updated considerations on current management modalities. 
  • VA-ECMO for cardiogenic shock in the contemporary era of heart transplantation: Which patients should be urgently transplanted? 
  • Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study. 
  • Vagal nerve stimulation modulates gut injury and lung permeability in trauma-hemorrhagic shock. 
  • Vagotomy/drainage is superior to local oversew in patients who require emergency surgery for bleeding peptic ulcers. 
  • Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters in Predicting Prognosis for Patients With Cervical Cancer. 
  • Value of fourth and subsequent post-therapy follow-up 18F-FDG PET/CT scans in patients with breast cancer. 
  • Valve surgery in octogenarians: in-hospital and long-term outcomes. 
  • Variability in donor organ offer acceptance and lung transplantation survival. 
  • Variability in survival and post-cardiac arrest care following successful resuscitation from out-of-hospital cardiac arrest. 
  • Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer. 
  • Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. 
  • Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure. 
  • Variables in predicting survival based on treating "PSA-only" relapse. 
  • Variables of importance in the Scientific Registry of Transplant Recipients database predictive of heart transplant waitlist mortality. 
  • Variant prostate carcinoma and elevated serum CA-125. 
  • Variation in ventilation time after coronary artery bypass grafting: an analysis from the society of thoracic surgeons adult cardiac surgery database. 
  • Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial. 
  • Vascular factors predict rate of progression in Alzheimer disease. 
  • Vascularized composite allotransplantation in the United States: A descriptive analysis of the Organ Procurement and Transplantation Network Data. 
  • Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy. 
  • Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study. 
  • Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients. 
  • Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. 
  • Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches. 
  • Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. 
  • Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor. 
  • Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study. 
  • Vitamin D and prostate cancer survival in veterans. 
  • Volume effect in paediatric brain tumour resection surgery: analysis of data from the Japanese national inpatient database. 
  • Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma. 
  • Wake Forest University long-term follow-up of type 2 myocardial infarction: The Wake-Up T2MI Registry. 
  • Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillation. 
  • Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience. 
  • Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact? 
  • West syndrome in tuberous sclerosis complex. 
  • What threshold for adjuvant therapy in older breast cancer patients? 
  • Whole blood cells loaded with messenger RNA as an anti-tumor vaccine. 
  • Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. 
  • Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update. 
  • Whole-exome sequencing identifies novel somatic alterations associated with outcomes in idiopathic multicentric Castleman disease. 
  • Why the Authors Use Cardiac Resynchronization Therapy with Defibrillators. 
  • Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF). 
  • Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons? 
  • X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model. 
  • Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009. 
  • Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010. 
  • Yin yang 1 modulates taxane response in epithelial ovarian cancer. 
  • Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge. 
  • Ziv-aflibercept: binding to more than VEGF-A--does more matter? 
  • [18F]fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma. 
  • [A study of E-cadherin and beta-catenin expression and their correlation with prognosis of nonsmall cell lung carcinoma]. 
  • [Primary chemotherapy in the treatment of breast cancer]. 
  • [Tumor regression as a prognostic factor in breast cancer]. 
  • miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy. 
  • nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors. 
  • p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck. 
  • μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Buckley, Rebecca Hatcher, James Buren Sidbury Distinguished Professor Emeritus of Pediatrics, in the School of Medicine, Pediatrics, Allergy and Immunology
  • Chen, Jun, Professor of Medicine, Duke Cancer Institute
  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • Esclamado, Ramon Mitra, Richard Hall Chaney, Sr. Distinguished Professor Emeritus of Otolaryngology, Head and Neck Surgery & Communication Sciences
  • Halabi, Susan, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Lee, Walter T, Professor of Head and Neck Surgery & Communication Sciences, Radiation Oncology
  • McLendon, Roger Edwin, Professor of Pathology, Pathology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Moorman, Patricia Gripka, Professor Emeritus in Family Medicine and Community Health, Duke Cancer Institute
  • Muh, Carrie Rebecca, Adjunct Assistant Professor in the Department of Neurosurgery, Neurosurgery
  • Muhlbaier, Lawrence H., Associate Professor Emeritus of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Pang, Herbert, Adjunct Assistant Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology
  • Pitt, Geoffrey Stuart, Adjunct Professor in the Department of Medicine, Medicine, Cardiology
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Biomedical Engineering
  • Uronis, Hope Elizabeth, Associate Professor of Medicine, Medicine, Medical Oncology
  • Weinhold, Kent James, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Integrative Immunobiology
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine
  • Zafar, Syed Yousuf, Adjunct Professor in the Department of Medicine, Duke Science & Society
  • Zhong, Xiaoping, Professor of Pediatrics, Integrative Immunobiology